1
since this page started loading...
💀
Source Quotes and References
Keywords
war-on-disease, 1-percent-treaty, medical-research, public-health, peace-dividend, decentralized-trials, dfda, dih, victory-bonds, health-economics, cost-benefit-analysis, clinical-trials, drug-development, regulatory-reform, military-spending, peace-economics, decentralized-governance, wishocracy, blockchain-governance, impact-investing
1.
School, H. K. 3.5% participation tipping point.
Harvard Kennedy School https://www.hks.harvard.edu/centers/carr/publications/35-rule-how-small-minority-can-change-world
(2020)
The research found that nonviolent
campaigns were twice as likely to succeed as violent ones, and once 3.5%
of the population were involved, they were always successful. Chenoweth
and Maria Stephan studied the success rates of civil resistance efforts
from 1900 to 2006, finding that nonviolent movements attracted, on
average, four times as many participants as violent movements and were
more likely to succeed. Key finding: Every campaign that mobilized at
least 3.5% of the population in sustained protest was successful (in
their 1900-2006 dataset) Note: The 3.5% figure is a descriptive
statistic from historical analysis, not a guaranteed threshold. One
exception (Bahrain 2011-2014 with 6%+ participation) has been
identified. The rule applies to regime change, not policy change in
democracies. Additional sources:
https://www.hks.harvard.edu/centers/carr/publications/35-rule-how-small-minority-can-change-world
|
https://www.hks.harvard.edu/sites/default/files/2024-05/Erica%20Chenoweth_2020-005.pdf
|
https://www.bbc.com/future/article/20190513-it-only-takes-35-of-people-to-change-the-world
| https://en.wikipedia.org/wiki/3.5%25_rule
.2.
UNICEF. Annual
child deaths statistic. (2024)
15,000 are
children (based on 5 million annual child deaths)
.3.
CDC.
Percentage
of preventable deaths. vol. 73 (2024)
80,000 were preventable (53% of deaths are
preventable)
.4.
GAO.
95% of diseases have 0 FDA-approved treatments. GAO https://www.gao.gov/products/gao-25-106774
(2025)
95% of diseases have no treatment
Additional sources: https://www.gao.gov/products/gao-25-106774 |
https://globalgenes.org/rare-disease-facts/
.5.
PMC,
S. et al. |. FAERS adverse event underreporting rate. PubMed:
Empirical estimation of under-reporting in FAERS https://pubmed.ncbi.nlm.nih.gov/28447485/
(2017)
Empirical estimation: Average
reporting rate approximately 6%, meaning 94% of adverse events are
underreported Variability: 0.01% to 44% for statin events; 0.002% to
>100% for biological drugs; 20% to >100% for narrow therapeutic
index (NTI) drugs Selective reporting: Serious, unusual events more
likely reported than mild or expected ones Newly marketed drugs: Higher
reporting rates due to heightened awareness Older drugs: Events often
under-reported Note: FAERS voluntary reporting system captures only "tip
of the iceberg" of drug safety problems. Under-reporting introduces
inherent biases and limitations in pharmacovigilance data Additional
sources: https://pubmed.ncbi.nlm.nih.gov/28447485/ |
https://pmc.ncbi.nlm.nih.gov/articles/PMC12393772/
.6.
Congress.gov. Passage of the affordable care
act and pelosi quote. Congress.gov https://www.congress.gov/bill/111th-congress/house-bill/3590/text
The Affordable Care Act: 2,700 pages, "we have to
pass it to see what’s in it. Additional sources:
https://www.congress.gov/bill/111th-congress/house-bill/3590/text |
https://www.snopes.com/fact-check/pelosi-healthcare-pass-the-bill-to-see-what-is-in-it/
.7.
PMC.
Aging reversal demonstrated in mammals using yamanaka factors. PMC:
Chemically Induced Reprogramming to Reverse Aging https://pmc.ncbi.nlm.nih.gov/articles/PMC10373966/
(2023)
Harvard/Sinclair: Loss of epigenetic
information causes aging; restoring epigenome integrity reverses aging
signs in mice OSK therapy (Oct4, Sox2, Klf4): Ectopic induction can
restore youthful DNA methylation patterns, transcript profiles, and
tissue function without erasing cellular identity Results in mice:
Systemically delivered adeno-associated viruses encoding inducible OSK
in 124-week-old mice extended median remaining lifespan by 109% over
wild-type controls Vision restored in glaucoma mice - first successful
reversal (not just halting progression) Cyclic partial reprogramming (2
days on, 5 days off) showed improvements after just 6 weeks including
reduced age-related spinal curvature Human cells: Babraham Institute
showed cellular reprogramming reverses epigenetic age of human skin
cells by 30 years Chemical alternatives: Six chemical cocktails
identified that restore youthful genome-wide transcript profile in less
than a week without compromising cellular identity Note: Demonstrates
biological aging is reversible, not inevitable; safety testing ongoing
before human application Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10373966/ |
https://www.nature.com/articles/s41467-024-46020-5 |
https://www.liebertpub.com/doi/10.1089/cell.2023.0072 |
https://clinicalepigeneticsjournal.biomedcentral.com/articles/10.1186/s13148-021-01158-7
.8.
Association, A. Annual deaths from alzheimer’s
and other dementias. Alzheimer’s Association https://www.alz.org/alzheimers-dementia/facts-figures
(2024)
Alzheimer’s | 2.6M deaths/year
Additional sources:
https://www.alz.org/alzheimers-dementia/facts-figures |
https://www.cdc.gov/nchs/fastats/alzheimers.htm
.9.
Antimicrobial Resistance, R. on. Antimicrobial
resistance deaths projection. Review on Antimicrobial
Resistance https://amr-review.org/sites/default/files/160525_Final\%20paper_with\%20cover.pdf
(2016).
10.
Data, O. W. in. Animal diseases eradicated by
veterinary science. Our World in Data: Rinderpest Eradication
https://ourworldindata.org/how-rinderpest-was-eradicated
Rinderpest eradicated in 2011 - only second
disease ever eradicated after smallpox Declared globally eradicated by
UN FAO and World Organisation for Animal Health Greatest veterinary
achievement of our time" - devastating livestock disease for centuries
Note: Caused up to 90% mortality in affected herds. Eradication achieved
through coordinated international vaccination campaign launched in 1994
Additional sources:
https://ourworldindata.org/how-rinderpest-was-eradicated |
https://www.woah.org/en/disease/rinderpest/
.11.
NIH. Antidepressant clinical trial exclusion
rates. Zimmerman et al. https://pubmed.ncbi.nlm.nih.gov/26276679/
(2015)
Mean exclusion rate: 86.1% across 158
antidepressant efficacy trials (range: 44.4% to 99.8%) More than 82% of
real-world depression patients would be ineligible for antidepressant
registration trials Exclusion rates increased over time: 91.4%
(2010-2014) vs. 83.8% (1995-2009) Most common exclusions: comorbid
psychiatric disorders, age restrictions, insufficient depression
severity, medical conditions Emergency psychiatry patients: only 3.3%
eligible (96.7% excluded) when applying 9 common exclusion criteria Only
a minority of depressed patients seen in clinical practice are likely to
be eligible for most AETs Note: Generalizability of antidepressant
trials has decreased over time, with increasingly stringent exclusion
criteria eliminating patients who would actually use the drugs in
clinical practice Additional sources:
https://pubmed.ncbi.nlm.nih.gov/26276679/ |
https://pubmed.ncbi.nlm.nih.gov/26164052/ |
https://www.wolterskluwer.com/en/news/antidepressant-trials-exclude-most-real-world-patients-with-depression
.12.
Legal, U. Arms trade treaty (2013) - campaign
and adoption. UN Legal https://legal.un.org/avl/ha/att/att.html
The Arms Trade Treaty (ATT) regulates
international trade in conventional arms. Adopted by UN General Assembly
April 2, 2013. Campaign duration: 10 years (2003-2013) by Control Arms
coalition Started with only 3 governments supporting (Mali, Costa Rica,
Cambodia); achieved 130 signatories Coalition published 50+ reports over
the campaign period One of the fastest multilateral treaties to enter
into force after opening for signature Additional sources:
https://legal.un.org/avl/ha/att/att.html | https://controlarms.org/att/
|
https://www.oxfamamerica.org/about-us/measuring-impact/global-arms-trade-treaty/the-international-arms-trade-treaty/
|
https://www.armscontrol.org/factsheets/arms_trade_treaty
.13.
FDAReview.org. Estimated deaths due to FDA
delay in approving beta blockers. FDAReview.org: FDA Harm https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/
(2011)
Beta blockers approved in Europe
mid-1970s, FDA didn’t approve until 1981 FDA estimated the drug could
save 17,000 lives/year after approval Estimated 100,000 deaths from
secondary heart attacks during 6-7 year delay Note: FDA imposed
moratorium due to possible animal carcinogenicity despite human clinical
evidence from 1974 Additional sources:
https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/
|
https://www.ocregister.com/2011/02/09/walter-williams-death-by-fda-delay-denials/
.14.
Wikipedia. Examples of biological immortality
and extreme longevity in nature. Wikipedia: Biological
Immortality https://en.wikipedia.org/wiki/Biological_immortality
Hydra: Biologically immortal - no mortality
increase over 4-year study, kept alive 12+ years Planarian worms:
Somatically immortal with limitless telomere regeneration, clonal lines
>15 years Axolotls: Regrow limbs, brain parts, heart tissue through
remarkable regeneration Naked mole rats: Live 37+ years (10x similar
rodents), cancer-proof, no age-related mortality increase Bowhead
whales: Live 200+ years, unique DNA repair mutations, extra
cancer-suppression genes Note: These animals demonstrate enhanced DNA
repair, abundant stem cells, telomerase activity, and cancer resistance
Additional sources: https://en.wikipedia.org/wiki/Biological_immortality
| https://pmc.ncbi.nlm.nih.gov/articles/PMC5807068/
.15.
Labor Statistics, U. S. B. of. CPI inflation
calculator. (2024)
CPI-U (1980): 82.4
CPI-U (2024): 313.5 Inflation multiplier (1980-2024): 3.80× Cumulative
inflation: 280.48% Average annual inflation rate: 3.08% Note: Official
U.S. government inflation data using Consumer Price Index for All Urban
Consumers (CPI-U). Additional sources:
https://www.bls.gov/data/inflation_calculator.htm
.16.
arXiv. Bradley-terry and PageRank models for
ranking. arXiv: PageRank and Bradley-Terry Model https://arxiv.org/abs/2402.07811
Bradley-Terry: Probability model for pairwise
comparisons (1952, earlier by Zermelo 1920s); maximum likelihood
estimation PageRank: Ranks nodes by importance in network via stationary
distribution of Markov chain Connection: Under quasi-symmetry,
Bradley-Terry scores are equivalent to scaled PageRank; ML estimates can
be approximated from limiting distribution Applications: Sports
rankings, journal citations, AI model rankings, consumer choice, search
engines Additional sources: https://arxiv.org/abs/2402.07811 |
https://en.wikipedia.org/wiki/Bradley–Terry_model |
https://www.sciencedirect.com/science/article/pii/S0950705122000314
.17.
Review, M. T. Brian armstrong’s investments in
health tech. MIT Tech Review: Armstrong CRISPR Investment https://www.technologyreview.com/2025/06/05/1117909/crypto-billionaire-brian-armstrong-is-ready-to-invest-in-crispr-baby-tech/
(2025)
ResearchHub (2020): Scientific
research platform, raised $5M Series A (2023), uses crypto to
incentivize research NewLimit (2022): Longevity/aging company using
epigenetic reprogramming, raised $130M Funding CRISPR baby tech: First
major commercial investment in gene-editing human embryos Note: Coinbase
CEO using crypto wealth to fund radical health/longevity ventures.
Co-founder Blake Byers advocates significant GDP spending on
"immortality" research Additional sources:
https://www.technologyreview.com/2025/06/05/1117909/crypto-billionaire-brian-armstrong-is-ready-to-invest-in-crispr-baby-tech/
|
https://finance.yahoo.com/news/coinbase-ceo-brian-armstrong-researchhub-150712331.html
.19.
Lancet, T. Annual deaths from cancer (10
million). The Lancet: Global Cancer Deaths 2023 https://www.hematologyadvisor.com/news/globally-18-5-million-incident-cancer-cases-and-10-4-million-deaths-reported-in-2023/
(2023)
Cancer deaths: 10.4 million globally
in 2023 (9.7 million in 2022) 18.5 million new cancer cases in 2023
65.8% of deaths occur in low- to upper-middle-income countries Note:
Cancer is the second leading cause of death globally after
cardiovascular diseases. Projected to reach 18.6 million deaths by 2050
(74.5% increase) Additional sources:
https://www.hematologyadvisor.com/news/globally-18-5-million-incident-cancer-cases-and-10-4-million-deaths-reported-in-2023/
|
https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing–amidst-mounting-need-for-services
.20.
General, C. A. California consumer privacy act
(CCPA) and california privacy rights act (CPRA). CA Attorney
General: CCPA https://oag.ca.gov/privacy/ccpa
CCPA effective January 1, 2020; CPRA (Prop 24)
approved November 2020, effective January 1, 2023 Consumer rights:
Know/access personal data; Delete data; Opt-out of sale/sharing;
Non-discrimination; Correct inaccurate data (CPRA); Limit sensitive data
use (CPRA) Enforcement: California Privacy Protection Agency (CPRA
created); Previously CA Attorney General Penalties: Up to $7,500 per
intentional violation; $2,500 per unintentional violation Additional
sources: https://oag.ca.gov/privacy/ccpa |
https://cppa.ca.gov/regulations/ |
https://pro.bloomberglaw.com/insights/privacy/california-consumer-privacy-laws/
.21.
NPR. Contamination of early CDC COVID-19 tests
in 2020. NPR: CDC Test Flawed https://www.npr.org/2020/11/06/929078678/cdc-report-officials-knew-coronavirus-test-was-flawed-but-released-it-anyway
(2020)
CDC distributed flawed test kits Feb
6, 2020 - contaminated reagents caused false positives 24 of 26 public
health labs found contamination, CDC recalled kits by Feb 10 Tests made
in CDC lab (not manufacturing facility), violated sound manufacturing
practices Contamination occurred in Respiratory Virus Diagnostic Lab
during processing Note: Delays had significant consequences for early
pandemic tracking and response Additional sources:
https://www.npr.org/2020/11/06/929078678/cdc-report-officials-knew-coronavirus-test-was-flawed-but-released-it-anyway
|
https://www.cnn.com/2020/04/18/politics/cdc-coronavirus-testing-contamination/index.html
.22.
American, S. Cellular turnover and repair rates
in the human body. HowStuffWorks: Body Replace Every 7 Years https://www.scientificamerican.com/article/our-bodies-replace-billions-of-cells-every-day/
330 billion cells replaced daily ( 1% of all
cells, 3.8 million/second) 80 grams of cellular mass turnover per day,
dominated by blood cells (86%) and gut epithelial cells (12%) Complete
body cell replacement in 80-100 days (average cell age: 7 years) Note:
Despite constant regeneration, we age due to DNA mutations that
accumulate as cells replicate Produce 2 million red blood cells per
second Generate new stomach lining every 3-5 days Replace your entire
skin every 28 days (surface cells every 2-4 weeks) Rebuild your skeleton
every 10 years Additional sources:
https://www.scientificamerican.com/article/our-bodies-replace-billions-of-cells-every-day/
|
https://wis-wander.weizmann.ac.il/life-sciences/cell-replacement-numbers
|
https://science.howstuffworks.com/life/cellular-microscopic/does-body-really-replace-seven-years.htm
|
https://www.livescience.com/33179-does-human-body-replace-cells-seven-years.html
|
https://www.sanitas.com/en/magazine/body/about-body/how-our-body-regenerates.html
.23.
FDA. FDA regulations for charging for
investigational drugs (21 CFR 312.8). 21 CFR 312.8 https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-312/subpart-A/section-312.8
Sponsors may charge for investigational drugs
under expanded access with prior FDA authorization Can recover direct
costs (manufacturing, shipping) + monitoring/admin costs for treatment
INDs Must not interfere with drug development for marketing approval
Authorization valid for 1 year; requires independent CPA review of cost
calculations Note: Allows cost recovery but not profit; ensures patients
can access investigational drugs while development continues Additional
sources:
https://www.ecfr.gov/current/title-21/chapter-I/subchapter-D/part-312/subpart-A/section-312.8
| https://www.fda.gov/media/176308/download
.24.
Post, W. Chan zuckerberg initiative
funding/pledge. Washington Post: Zuckerberg $45B Pledge https://www.washingtonpost.com/news/the-switch/wp/2015/12/01/mark-zuckerberg-will-give-away-99-percent-of-his-facebook-stock/
(2015)
Zuckerberg & Chan pledged 99% of
Facebook stock worth $45 billion (2015) Structured as LLC (not
traditional foundation) to enable investments, policy advocacy Started
with $1 billion/year in Facebook stock for first 3 years Focus:
personalized learning, curing disease, connecting people, building
communities Note: One of largest-ever philanthropic commitments,
announced with birth of daughter Max in Dec 2015 Additional sources:
https://www.washingtonpost.com/news/the-switch/wp/2015/12/01/mark-zuckerberg-will-give-away-99-percent-of-his-facebook-stock/
|
https://www.philanthropy.com/article/zuckerberg-and-chan-pledge-nearly-45-billion-to-improving-this-world/
.25.
Institute, C. Chance of dying from terrorism
statistic. Cato Institute: Terrorism and Immigration Risk
Analysis https://www.cato.org/policy-analysis/terrorism-immigration-risk-analysis
Chance of American dying in foreign-born
terrorist attack: 1 in 3.6 million per year (1975-2015) Including 9/11
deaths; annual murder rate is 253x higher than terrorism death rate More
likely to die from lightning strike than foreign terrorism Note:
Comprehensive 41-year study shows terrorism risk is extremely low
compared to everyday dangers Additional sources:
https://www.cato.org/policy-analysis/terrorism-immigration-risk-analysis
|
https://www.nbcnews.com/news/us-news/you-re-more-likely-die-choking-be-killed-foreign-terrorists-n715141
.26.
Reymond, J. L. Total drug-like chemical space
(10^23 - 10^60). Reymond https://pubs.acs.org/doi/10.1021/ar500432k
(2015)
Estimated 10^23 to 10^60 drug-like
molecules exist in chemical space, dwarfing the number of compounds ever
synthesized. Additional sources:
https://pubs.acs.org/doi/10.1021/ar500432k
.27.
CDC. Childhood vaccination (US) ROI.
CDC https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6316a4.htm
(2017).
28.
Wikipedia. Cost of china’s military parades.
Wikipedia: 2015 China Victory Day Parade https://en.wikipedia.org/wiki/2015_China_Victory_Day_Parade
(2015)
2015 Victory Day (70th anniversary):
12,000 PLA troops, 1,000 foreign troops, 850,000 "Citizen Guards 2025
parade estimated >36 billion yuan ($5 billion, 1.5% of military
budget) - Taiwan estimate Beijing rarely discloses parade costs;
estimates cannot be independently verified Note: Massive mobilization
for propaganda purposes; costs remain state secret Additional sources:
https://en.wikipedia.org/wiki/2015_China_Victory_Day_Parade |
https://www.nbcnews.com/world/asia/live-blog/china-parade-putin-kim-jong-un-xi-military-live-updates-rcna228503
.29.
Parliament, U. Winston churchill quote on
democracy. UK Parliament https://api.parliament.uk/historic-hansard/commons/1947/nov/11/parliament-bill
(1947)
Democracy is the worst form of
government, except for all the others. Additional sources:
https://api.parliament.uk/historic-hansard/commons/1947/nov/11/parliament-bill
|
https://winstonchurchill.org/resources/quotes/the-worst-form-of-government/
.30.
United States, S. C. of the. Impact of citizens
united supreme court decision on campaign finance. Citizens United
v. FEC https://supreme.justia.com/cases/federal/us/558/310/
Citizens United v. FEC (2010): 5-4 Supreme Court
decision allowing unlimited corporate/union political spending Overruled
restrictions on independent expenditures, citing First Amendment Led to
creation of super PACs and massive increases in dark money Dramatically
expanded influence of wealthy donors, corporations, special interest
groups Note: Overwhelming majorities of Americans disapprove; 22+ states
voted to support constitutional amendment to overturn Additional
sources: https://supreme.justia.com/cases/federal/us/558/310/ |
https://www.brennancenter.org/our-work/research-reports/citizens-united-explained
.31.
Annenberg. Survey of american civic literacy
(congress’s function). Annenberg: Americans’ Civic Knowledge https://www.annenbergpublicpolicycenter.org/americans-know-surprisingly-little-about-their-government-survey-finds/
64% can’t name or describe three branches of
government Only 25% can name all three branches (down from 38% in 2011)
27% know 2/3 vote needed to override veto 70%+ fail basic civic literacy
quiz Note: Elected officials score worse (44%) than general public
(49%). 54% of elected officials don’t know Congress has power to declare
war Additional sources:
https://www.annenbergpublicpolicycenter.org/americans-know-surprisingly-little-about-their-government-survey-finds/
|
https://www.uschamberfoundation.org/civics/new-study-finds-alarming-lack-of-civic-literacy-among-americans
.32.
News, U. Clean water & sanitation (LMICs)
ROI. UN News https://news.un.org/en/story/2014/11/484032
(2014).
33.
Medicine, J. I. Cost breakdown of traditional
clinical trials. JAMA Internal Medicine: Clinical Trial Costs
Study https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287
Median clinical trial cost: $19.0 million (range:
$12.2M - $33.1M) Cost per patient varies by phase: Phase 1: $137K,
Phase 2: $130K, Phase 3: $113K Note: Based on analysis of 138 clinical
trials. Actual costs can vary significantly based on disease area, trial
complexity, and patient population Additional sources:
https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2702287
.34.
Arena, C. T. Clinical trial enrollment
timelines. Clinical Trials Arena https://www.clinicaltrialsarena.com/marketdata/featureclinical-trial-patient-recruitment/.
35.
Fortune Business Insights, M. Global clinical
trials market size. Fortune Business Insights https://www.fortunebusinessinsights.com/clinical-trials-market-106930
(2024)
Global clinical trials market valued
at USD 60.94 billion in 2024, projected to grow from USD 64.94 billion
in 2025 to USD 104.41 billion by 2032. Alternative estimate: USD 59
billion in 2024, growing to USD 98.9 billion by 2034. Additional
sources:
https://www.fortunebusinessinsights.com/clinical-trials-market-106930 |
https://www.gminsights.com/industry-analysis/clinical-trials-market
.36.
CAN, A. Clinical trial patient participation
rate. ACS CAN: Barriers to Clinical Trial Enrollment https://www.fightcancer.org/policy-resources/barriers-patient-enrollment-therapeutic-clinical-trials-cancer
Only 3-5% of adult cancer patients in US receive
treatment within clinical trials About 5% of American adults have ever
participated in any clinical trial Oncology: 2-3% of all oncology
patients participate Contrast: 50-60% enrollment for pediatric cancer
trials (<15 years old) Note: 20% of cancer trials fail due to
insufficient enrollment; 11% of research sites enroll zero patients
Additional sources:
https://www.fightcancer.org/policy-resources/barriers-patient-enrollment-therapeutic-clinical-trials-cancer
|
https://hints.cancer.gov/docs/Briefs/HINTS_Brief_48.pdf
.37.
via, D. analysis. ClinicalTrials.gov cumulative
enrollment data (2025). Direct analysis via ClinicalTrials.gov API
v2 https://clinicaltrials.gov/data-api/api
Analysis of 100,000 active/recruiting/completed
trials on ClinicalTrials.gov (November 2025) shows cumulative enrollment
of 12.2 million participants: Phase 1 (722k), Phase 2 (2.2M), Phase 3
(6.5M), Phase 4 (2.7M). Median participants per trial: Phase 1 (33),
Phase 2 (60), Phase 3 (237), Phase 4 (90). Additional sources:
https://clinicaltrials.gov/data-api/api
.38.
Cluster Munitions, C. on. Convention on cluster
munitions (2008) - oslo process. Convention on Cluster
Munitions https://www.clusterconvention.org/oslo-process/
The Convention on Cluster Munitions bans the use,
production, stockpiling, and transfer of cluster munitions. Oslo Process
timeline: February 2007 to December 2008 ( 2 years) 46 states signed
Oslo Declaration (Feb 2007); 94 states signed convention (Dec 2008) Core
Group: Norway, Austria, Ireland, Mexico, New Zealand, Peru, Holy See
Results: 29 States Parties destroyed nearly 1.4 million stockpiled
cluster munitions containing 172.9 million submunitions Additional
sources: https://www.clusterconvention.org/oslo-process/ |
https://unidir.org/files/publication/pdfs/unacceptable-harm-a-history-of-how-the-treaty-to-ban-cluster-munitions-was-won-en-258.pdf
|
https://www.stopclustermunitions.org/en-gb/the-treaty/global-ban.aspx
.39.
Miller, G. A. Cognitive limit in short-term
memory (miller’s law). George A. Miller https://doi.org/10.1037/h0043158
(1956)
Short-term memory capacity: 7 ± 2
items (Miller’s Law) The "magical number seven" - humans can hold
approximately 7 chunks of information in working memory Note: This
classic psychology paper has been cited over 40,000 times and
fundamentally shaped our understanding of human cognitive limitations
Additional sources: https://doi.org/10.1037/h0043158
.40.
Minutes, C. 60. Percentage of time members of
congress spend fundraising. CBS 60 Minutes: Congressional
Telemarketers https://www.cbsnews.com/news/60-minutes-are-members-of-congress-becoming-telemarketers/
Recommended: 4 hours "call time" + 1 hour
"strategic outreach" = 5 hours/day out of 9-10 hour workday New members
told to spend 30 hours/week on fundraising calls since Citizens United
Tom Daschle: 67% of schedule is money-gathering in 2 years before
election Only 3-4 hours/day for actual Congressional work (hearings,
votes, constituents) Note: By law, members cannot fundraise from
offices; parties set up call centers near Capitol Additional sources:
https://www.cbsnews.com/news/60-minutes-are-members-of-congress-becoming-telemarketers/
|
https://www.huffpost.com/entry/call-time-congressional-fundraising_n_2427291
.41.
Military.com. Congress adding funds to military
budget not requested by the pentagon. Military.com: $15B Unrequested
Weapons https://www.military.com/daily-news/2025/04/03/capitol-hill-wants-15-billion-weapons-pentagon-didnt-seek-report.html
(2025)
FY2025: $15 billion unrequested for
hundreds of military programs FY2023: $61.4 billion for all categories
of military spending (not requested) FY2022: $58 billion worth of
military projects (not requested) Past 4 years: >$100 billion for
2,000+ weapons programs (no public debate) Note: Bipartisan phenomenon;
most additions <$30M but add up substantially Additional sources:
https://www.military.com/daily-news/2025/04/03/capitol-hill-wants-15-billion-weapons-pentagon-didnt-seek-report.html
|
https://rollcall.com/2025/09/16/hill-added-100-billion-plus-since-2022-on-unrequested-weapons/
.42.
One, I. Congressional committee assignments
have explicit fundraising price tags. Issue One: The Price of
Power https://www.issueone.org/wp-content/uploads/2017/05/price-of-power-final.pdf
(2017)
DCCC (Democratic): Speaker $31
million, "A" Committee Chairs $1.8 million, Regular members $150,000
minimum NRCC (Republican): Speaker $20 million, Power Committee Chairs
$1.2 million, Transportation Chair $875,000 Members display "giant tally
sheet" showing who has/hasn’t paid their party dues Members who don’t
pay dues get bills killed, amendments ignored, worse offices Rep. Brett
Guthrie: Paid $2.5 million (53% of campaign funds) for Energy &
Commerce Chair Rep. Rosa DeLauro: Paid $690,000 (39% of campaign funds)
for Appropriations Note: System criticized as "recipe for corruption"
disconnecting members from constituents Additional sources:
https://www.issueone.org/wp-content/uploads/2017/05/price-of-power-final.pdf
| https://theintercept.com/2019/09/03/dccc-house-committees-dues/ |
https://www.brookings.edu/articles/problems-with-the-committee-tax-in-congress/
|
https://rollcall.com/2023/02/09/gavels-for-top-house-committees-dont-always-come-cheap/
.43.
Senate, U. S. Salary of a u.s. congressman.
U.S. Senate: Salaries https://www.senate.gov/senators/SenateSalariesSince1789.htm
Members of Congress: $174,000/year (2009-present)
Speaker of the House: $223,500/year Majority/Minority Leaders:
$193,400/year Note: Congressional salary has been frozen at $174,000
since 2009, unchanged for over 15 years Additional sources:
https://www.senate.gov/senators/SenateSalariesSince1789.htm |
https://crsreports.congress.gov
.44.
ScienceDaily. Conscious mind controls 5% of
decisions. ScienceDaily: Unconscious Decision Making https://www.sciencedaily.com/releases/2008/04/080414145705.htm
(2008)
Conscious of only 5% of cognitive
activity; 95% is unconscious/subconscious Brain signals predict
decisions up to 7 seconds before conscious awareness 90% of buying
decisions made subconsciously Most of what we do every minute is
unconscious" - neuroscientist Paul Whelan Note: All decisions made
unconsciously first, then we "fool ourselves" into believing we
consciously made them Additional sources:
https://www.sciencedaily.com/releases/2008/04/080414145705.htm |
https://pmc.ncbi.nlm.nih.gov/articles/PMC2440575/
.45.
Wikipedia. Control arms coalition - arms trade
treaty campaign. Wikipedia https://en.wikipedia.org/wiki/Control_Arms_Campaign
Coalition of 100+ organizations including Amnesty
International, Oxfam, and International Action Network on Small Arms
(IANSA) Campaign duration: 10 years (October 2003 - April 2013)
Published 50+ reports over the campaign period on various aspects of
arms trade regulation Campaign tactics: Publicity stunts, mass public
actions, Million Faces petition, worldwide consultations, lobbying
Achievement: Arms Trade Treaty adopted by UN General Assembly April
2013, entered into force December 2014 Additional sources:
https://en.wikipedia.org/wiki/Control_Arms_Campaign |
https://frompoverty.oxfam.org.uk/how-did-a-global-campaign-bring-about-a-un-arms-trade-treaty/
|
https://policy-practice.oxfam.org/resources/power-and-change-the-arms-trade-treaty-338471/
.46.
FTC. Children’s online privacy protection act
(COPPA). FTC: COPPA Rule https://www.ftc.gov/legal-library/browse/rules/childrens-online-privacy-protection-rule-coppa
Federal law effective April 21, 2000; applies to
websites/services collecting data from children under 13 Requirements:
Privacy policy; Verifiable parental consent before collecting data; Data
security; Parental review/deletion rights Applies to: For-profit
businesses collecting personal info from US children under 13 Penalties:
Up to $50,120 per violation Enforcement: FTC and State Attorneys General
Additional sources:
https://www.ftc.gov/legal-library/browse/rules/childrens-online-privacy-protection-rule-coppa
| https://en.wikipedia.org/wiki/Children’s_Online_Privacy_Protection_Act
|
https://www.ecfr.gov/current/title-16/chapter-I/subchapter-C/part-312
.47.
Statista. Corporate lobbying spending in 2023.
Statista: Total Lobbying Spending 2023 https://www.statista.com/statistics/257337/total-lobbying-spending-in-the-us/
(2023).
48.
ScienceDirect. How campaign contributions
influence politicians. ScienceDirect: Campaign Contributions &
Legislative Behavior https://www.sciencedirect.com/science/article/pii/S0047272725000179
(2010)
Research: Only 1 in 4 studies support
notion that contributions directly "buy votes Influence mechanism:
Access, agenda-setting, keeping bills off floor, earmarks, key language
in legislation (not direct votes) Average winner costs (2022): House
$2.79M, Senate $26.53M; Competitive races much higher Internal party
fundraising requirements: $100K-$30M annually; Committee positions cost
$450K 95% of House races since 2004 won by highest spender Contribution
limits: $3,300 per candidate per election (individuals); PACs gave
$289.3M total (2021-2022) Additional sources:
https://www.sciencedirect.com/science/article/pii/S0047272725000179 |
https://slate.com/news-and-politics/2010/10/how-much-does-it-cost-to-buy-a-vote.html
| https://www.opensecrets.org/elections-overview/cost-of-election |
https://issueone.org/articles/the-118th-congress-fundraising-treadmill/
.49.
Statista. Comparison of u.s. Deaths from
COVID-19 vs. Major wars. Statista: COVID vs War Deaths https://www.statista.com/chart/24252/us-covid-19-deaths-compared-to-deaths-in-major-wars/
COVID-19 US deaths: 1.2+ million total (as of
2024) WWII: 405,000 | Korea: 36,000 | Vietnam: 58,000 = 499,000 combined
By March 2021: COVID deaths (527,726) exceeded WWI, WWII, Vietnam, 9/11
combined By Oct 2021: 704,233 deaths exceeded ALL US foreign conflict
deaths ( 685,000 total) Note: COVID killed more Americans than
Revolutionary War, War of 1812, WWI, WWII, Korea, Vietnam, and other
conflicts combined Additional sources:
https://www.statista.com/chart/24252/us-covid-19-deaths-compared-to-deaths-in-major-wars/
|
https://www.snopes.com/fact-check/americans-covid-foreign-conflicts/
.50.
al., R. et. Decentralized clinical trials (DCT)
cost reduction evidence. Rogers et al. https://discovery.dundee.ac.uk/ws/files/72718478/Brit_J_Clinical_Pharma_2022_Rogers_A_systematic_review_of_methods_used_to_conduct_decentralised_clinical_trials.pdf
(2022)
DCTs are developing rapidly. However,
there is insufficient evidence to confirm which methods are most
effective in trial recruitment, retention, or overall cost." Despite
this, DCTs have demonstrated potential for significant cost reductions
(20-50.0% or more) through reduced site management, travel, and
streamlined data collection. DCTs are considered cost-saving by reducing
the number of onsite patient visits and decreasing the costs related to
time for study nurses and clinicians. Additional sources:
https://discovery.dundee.ac.uk/ws/files/72718478/Brit_J_Clinical_Pharma_2022_Rogers_A_systematic_review_of_methods_used_to_conduct_decentralised_clinical_trials.pdf
| https://www.nature.com/articles/s41746-024-01214-5
.51.
HIT
Consultant, O. Medable DCT platform funding. HIT Consultant https://hitconsultant.net/2021/10/26/medable-dct-series-d-funding/
(2021)
Medable, a leader in the DCT platform
space, has raised a total of $521 million in capital, achieving a
valuation of $2.1 billion as of late 2021. This funding level shows what
it costs to build a global SaaS platform operating across 60+ countries
and capture significant market share. Additional sources:
https://hitconsultant.net/2021/10/26/medable-dct-series-d-funding/ |
https://informaconnect.com/decentralized-trial-tech-firm-medable-raises-another-300m/
.52.
MobiHealthNews, A. Other DCT platform company
funding. MobiHealthNews https://www.mobihealthnews.com/news/exo-raises-40m-handheld-ultrasound-decentralized-trial-platforms-raise-nearly-100m-and-more
(2020)
Science 37: $40M raised Thread: up to
$50M raised uMotif: $25.5M raised These companies show that you can
achieve significant traction and platform development with investments
in the tens of millions. Additional sources:
https://www.mobihealthnews.com/news/exo-raises-40m-handheld-ultrasound-decentralized-trial-platforms-raise-nearly-100m-and-more
|
https://www.pharmasalmanac.com/articles/umotif-the-patient-first-data-capture-and-decentralized-clinical-trials-platform-announces-25.5m-of-new-investment-from-a-fund-managed-by-athyrium-capital-management
.53.
IHME. Death causes vs fear (heart disease vs
terrorism). IHME: CVD Deaths 2023 https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023
(2023)
Cardiovascular disease: 19.2-20.5
million deaths annually (2023 data) Terrorism: approximately 25,000
deaths per year CVD accounts for 1 in 3 global deaths - the leading
cause for over 30 years Note: CVD deaths increased 60% from 12.1M (1990)
to 20.5M (2021). 4 in 5 CVD deaths occur in low- and middle-income
countries Additional sources:
https://www.healthdata.org/news-events/newsroom/news-releases/report-cardiovascular-diseases-caused-1-3-global-deaths-2023
|
https://world-heart-federation.org/wp-content/uploads/World-Heart-Report-2023.pdf
.54.
Corporations, D. D. of. Delaware has more
corporate entities than residents. Delaware Division of
Corporations: 2020 Annual Report https://corp.delaware.gov/stats/2020-annual-report/
(2020)
Delaware population: <1 million
residents Business entities: 1.6 million+ (2020) - 2:1 ratio over
residents 2019: 1.5 million entities vs <1M people 66% of Fortune 500
incorporated in Delaware 93% of US IPOs are Delaware entities Note:
249,427 new business entities added in 2020 alone. Unique 2:1
corporation-to-resident ratio Additional sources:
https://corp.delaware.gov/stats/2020-annual-report/ |
https://press.princeton.edu/ideas/hal-weitzman-on-whats-the-matter-with-delaware
.55.
Federation, I. D. Annual deaths from diabetes.
International Diabetes Federation https://diabetesatlas.org/
(2024)
Diabetes | 2M deaths/year Additional
sources: https://diabetesatlas.org/ |
https://www.who.int/news-room/fact-sheets/detail/diabetes
.56.
Stern, N. Lobbying spending and returns for
disease advocacy groups. NYU Stern: Lobbying Influences NIH
Funding https://www.stern.nyu.edu/experience-stern/news-events/new-research-finds-special-interest-lobbying-does-influence-nih-research-funding
(2024)
Each $1,000 spent on lobbying
correlated with $25,000 funding increase following year (53 diseases, 19
years) Rare disease advocates increased NIH rare-disease funding
3-15%/year (1998-2008) via millions in lobbying Specific examples:
Alzheimer’s Association secured $100M NIH increase (FY2024); ME/CFS
Initiative helped secure >$1B for long-COVID General ratio: Disease
advocacy lobbying yields significant ROI, though specific "$100M →
$1.8B" not verified Additional sources:
https://www.stern.nyu.edu/experience-stern/news-events/new-research-finds-special-interest-lobbying-does-influence-nih-research-funding
| https://www.nature.com/articles/515019a |
https://www.alz.org/news/2024/congress-bipartisan-funding-alzheimers-research
.57.
IHME Global Burden of Disease (2.55B DALYs), C.
from & GDP per capita valuation, global. $109 trillion annual global
disease burden.
The global economic burden of
disease, including direct healthcare costs (8.2trillion)andlostproductivity(100.9
trillion from 2.55 billion DALYs × 39, 570perDALY), totalsapproximately109.1
trillion annually.
58.
al., B. et. Disease network overlap (network
medicine). Barabási et al. https://www.nature.com/articles/nrg2918
(2011)
Diseases cluster on shared biological
networks, meaning drugs for one condition may plausibly affect many
others. Additional sources:
https://www.nature.com/articles/nrg2918
.59.
DOT. DOT value of statistical life ($13.6M).
DOT: VSL Guidance 2024 https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis
(2024)
Current VSL (2024): $13.7 million
(updated from $13.6M) Used in cost-benefit analyses for transportation
regulations and infrastructure Methodology updated in 2013 guidance,
adjusted annually for inflation and real income VSL represents aggregate
willingness to pay for safety improvements that reduce fatalities by one
Note: DOT has published VSL guidance periodically since 1993. Current
$13.7M reflects 2024 inflation/income adjustments Additional sources:
https://www.transportation.gov/office-policy/transportation-policy/revised-departmental-guidance-on-valuation-of-a-statistical-life-in-economic-analysis
|
https://www.transportation.gov/regulations/economic-values-used-in-analysis
.60.
Drugs.com. Time to develop one drug: 17 years.
Drugs.com https://www.drugs.com/fda-approval-process.html
Time to develop one drug: 17 years Additional
sources: https://www.drugs.com/fda-approval-process.html |
https://www.fdareview.org/issues/the-drug-development-and-approval-process/
.61.
Wikipedia. Drug price competition and patent
term restoration act of 1984. Wikipedia: Hatch-Waxman Act https://en.wikipedia.org/wiki/Drug_Price_Competition_and_Patent_Term_Restoration_Act
Also known as: Hatch-Waxman Act (Public Law
98-417) Signed by Reagan: September 24, 1984 Sponsors: Rep. Henry Waxman
(CA) and Sen. Orrin Hatch (UT) Created modern generic drug regulation
system via Abbreviated New Drug Applications (ANDAs) Patent term
extension: Up to 5 years (max 14 years total from approval) Generic
incentive: 180 days market exclusivity for first paragraph IV
certification 5-year data exclusivity for new chemical entities Note:
Landmark legislation balancing generic access with innovation
incentives. Generic manufacturers only need to show bioequivalence, not
repeat clinical trials Additional sources:
https://en.wikipedia.org/wiki/Drug_Price_Competition_and_Patent_Term_Restoration_Act
| https://www.congress.gov/bill/98th-congress/house-bill/3605 |
https://www.everycrsreport.com/reports/R44643.html
.62.
Institute, B. Drug repurposing hub (broad
institute). Broad Institute https://www.broadinstitute.org/drug-repurposing-hub
(2017)
The Drug Repurposing Hub contains
4,707 hand-curated compounds (later expanded to 6,801), including 3,422
drugs that are marketed or have been in clinical trials. The collection
includes 1,988 approved/marketed drugs and 1,348 compounds that cleared
at least phase 1 clinical testing. Additional sources:
https://www.broadinstitute.org/drug-repurposing-hub |
https://pmc.ncbi.nlm.nih.gov/articles/PMC5568558/
.63.
Dunbar, R. I. M. Dunbar’s number.
Dunbar <https://doi.org/10.1016/0047-2484(92
(1992)
The cognitive limit to the number of
people with whom one can maintain stable social relationships is
approximately 150. Additional sources:
<https://doi.org/10.1016/0047-2484(92
.64.
Ramsberg J, P. R. Opportunities and barriers
for pragmatic embedded trials: Triumphs and tribulations. Harvard
Medical School/Harvard Pilgrim Health Care Institute https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/
(2018)
**Meta-analysis of 108 embedded
pragmatic clinical trials** (2006-2016). The median cost per patient was
**$97** (mean $478) across all trials reviewed. 25% of studies cost less
than $19 per patient. US studies had higher median costs ($187 vs $27
non-US). Registry-based trials were less expensive than EHR-based
trials. Traditional RCT comparison: **$16,600/patient** (Berndt &
Cockburn 2014). The 108 trials had median enrollment of 5,540 patients
with broad eligibility criteria. 81% used cluster randomization. Trials
spanned 15 countries, infectious diseases (25%), cardiovascular (18%),
diabetes (12%). Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/
.65.
NIHR. England clinical trial participants
2023/24. NIHR https://www.nihr.ac.uk/about-us/who-we-are/reports-and-performance/annual-statistics
(2023)
1,045,282 participants recruited to
NIHR Clinical Research Network (CRN) supported studies in England in
2023/24, compared to 952,789 in 2022/23. Additional sources:
https://www.nihr.ac.uk/about-us/who-we-are/reports-and-performance/annual-statistics
.66.
War, B. W. C. of. Environmental cost of war
($100B annually). Brown Watson Costs of War: Environmental Cost
https://watson.brown.edu/costsofwar/costs/social/environment
War on Terror emissions: 1.2B metric tons GHG
(equivalent to 257M cars/year) Military: 5.5% of global GHG emissions
(2X aviation + shipping combined) US DoD: World’s single largest
institutional oil consumer, 47th largest emitter if nation Cleanup
costs: $500B+ for military contaminated sites Gaza war environmental
damage: $56.4B; landmine clearance: $34.6B expected Climate finance gap:
Rich nations spend 30X more on military than climate finance Note:
Military activities cause massive environmental damage through GHG
emissions, toxic contamination, and long-term cleanup costs far
exceeding current climate finance commitments Additional sources:
https://watson.brown.edu/costsofwar/costs/social/environment |
https://earth.org/environmental-costs-of-wars/ |
https://transformdefence.org/transformdefence/stats/
.67.
EPA. EPA value of statistical life ($9.6M).
EPA: Mortality Risk Valuation https://www.epa.gov/environmental-economics/mortality-risk-valuation
(2017)
EPA 2010 Guidelines: $7.9M (2008
dollars) → $9.7M (2013 dollars/income adjusted) Current EPA VSL: $10
million (highest among federal agencies) Based on 1997 Clean Air Act
analysis; updated for inflation/income but not methodology Uses
wage-risk literature (21 studies) and stated preference studies (5
studies) Used in cost-benefit analyses for environmental, health, and
safety regulations Note: $9.6-9.7M represents EPA’s VSL with
inflation/income adjustments. Base methodology hasn’t been updated since
1997 Additional sources:
https://www.epa.gov/environmental-economics/mortality-risk-valuation |
https://www.rff.org/publications/working-papers/revisiting-the-environmental-protection-agencys-value-of-statistical-life/
|
https://www.epa.gov/sites/default/files/2017-12/documents/ee-0483_all.pdf
.68.
e-Residency. Estonia e-residency statistics.
e-Residency https://www.e-resident.gov.ee/dashboard/
(2024)
Estonia’s e-Residency program has
issued digital identities to over 100,000 people from 170+ countries,
demonstrating global-scale digital identity verification. Additional
sources: https://www.e-resident.gov.ee/dashboard/
.69.
EMA. EU compassionate use program for
experimental drugs. EMA: Compassionate Use https://www.ema.europa.eu/en/human-regulatory-overview/research-development/compassionate-use
Established by: Article 83 of Regulation (EC) No
726/2004 Eligibility: Life-threatening, long-lasting, or seriously
debilitating illnesses Requires: No satisfactory authorized treatment;
medicine in trials or approval process EMA role: CHMP provides
recommendations; national authorities implement programs Pan-European
programs rare: Only 6 approved by EMA in last 10 years vs hundreds of
national programs Each EU member state sets own rules and procedures
Note: Pan-European framework exists but rarely used due to complex
navigation across varying national regulations. Most programs remain
country-specific Additional sources:
https://www.ema.europa.eu/en/human-regulatory-overview/research-development/compassionate-use
| https://pmc.ncbi.nlm.nih.gov/articles/PMC5116859/ |
https://www.eurordis.org/information-support/compassionate-use/
.70.
Strategy, E. D. EU eIDAS network for electronic
identification. EU Digital Strategy: eIDAS Regulation https://digital-strategy.ec.europa.eu/en/policies/eidas-regulation
(2014)
eIDAS = Electronic IDentification,
Authentication and trust Services Regulation (EU) No 910/2014 -
establishes framework for digital identity/authentication Mutual
recognition: Member states must recognize each other’s national eID
schemes Interoperability: Technology-neutral framework enabling seamless
cross-border authentication Levels of Assurance (LoA): Low, substantial,
or high confidence in identification eIDAS 2.0: Introduces European
Digital Identity Wallets (EUDI Wallets) - standardized throughout EU
Citizens/businesses can use eIDs from one member state to access
services in another Note: eIDAS 2.0 enhances original framework with
digital identity wallets operating seamlessly across all EU member
states. Crucial for secure cross-border electronic transactions
Additional sources:
https://digital-strategy.ec.europa.eu/en/policies/eidas-regulation |
https://eur-lex.europa.eu/eli/reg/2014/910/oj/eng |
https://en.wikipedia.org/wiki/EIDAS
.71.
Lieberman, D. Evolutionary mismatch and modern
disease. Lieberman https://www.penguinrandomhouse.com/books/206671/the-story-of-the-human-body-by-daniel-e-lieberman/
(2013)
Many modern diseases result from a
mismatch between our evolutionary adaptations and current environments,
particularly regarding diet and physical activity. Additional sources:
https://www.penguinrandomhouse.com/books/206671/the-story-of-the-human-body-by-daniel-e-lieberman/
.72.
PMC. Estimated excess deaths attributed to
FDA’s COVID-19 response. PMC: EUAs vs FDA Approval Implications
https://pmc.ncbi.nlm.nih.gov/articles/PMC8101583/
FDA regulations restricted clinician/patient
access to COVID-19 testing, remdesivir, vaccines General drug delay
estimate: 37,000-76,000 deaths per one-year delay Testing delays: By May
2020, 400+ applications awaiting FDA review Seattle lab ordered to stop
testing Feb 16 for lack of FDA approval Gates Foundation partnership
instructed to discontinue testing May 2020 until authorization EUA
process prevented months of vaccine/testing delays Note: Specific
"500,000+" figure not found in sources. Research shows FDA testing
restrictions caused weeks-to-months of critical delays (Feb-March 2020).
One-year drug delay = 37-76K deaths Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8101583/ |
https://pmc.ncbi.nlm.nih.gov/articles/PMC8012986/ |
https://www.yalelawjournal.org/forum/deadly-delay-the-fdas-role-in-americas-covid-testing-debacle
.73.
Statecraft, R. F-35 cost compared to global
rare disease research funding. Responsible Statecraft: F-35 Cost
$2T <https://responsiblestatecraft.org/f35-cost/>
Single F-35 cost: $82M (flyaway) to $110-136M
(with ancillary costs) NIH rare disease funding (FY2023): $6.9 billion
(world’s largest public biomedical research funder) NIH rare disease
funding = <0.1% of NIH’s $48B annual budget Comparison: 63 F-35s = 1
year of US rare disease research funding F-35 total program cost: $2.1
trillion lifetime (2,456 aircraft through 2088) Note: One F-35
($110-136M) doesn’t exceed annual rare disease funding ($6.9B), but
claim illustrates stark military vs medical research disparity. 63 F-35s
= entire year of rare disease research Additional sources:
<https://responsiblestatecraft.org/f35-cost/> |
https://www.statista.com/statistics/713320/rare-diseases-funding-by-the-national-institutes-for-health/
|
https://armscontrolcenter.org/f-35-joint-strike-fighter-costs-challenges/
.74.
GAO. F-35 program lifetime cost: $1.7 trillion.
GAO: F-35 Sustainment Costs https://www.gao.gov/products/gao-24-106703
(2024)
F-35 Program lifetime cost: $2.1
trillion (updated April 2024) Sustainment costs: $1.58 trillion (44%
increase from 2018 estimate) Procurement costs: $422 billion Covers 94
years of operation (through 2088) for 2,456 aircraft Note: About half
the cost increase is due to inflation. This makes the F-35 one of the
most expensive military acquisition programs in modern history
Additional sources: https://www.gao.gov/products/gao-24-106703 |
https://breakingdefense.com/2024/04/f-35-programs-lifetime-price-tag-tops-2-trillion-pentagon-wants-jets-to-fly-longer/
.75.
Drugs.com. FDA drug approval timeline.
Drugs.com: FDA Drug Approval Process https://www.drugs.com/fda-approval-process.html
Full timeline (preclinical to market): 12-15
years average (10-15 years common range) Preclinical phase: 3-7 years
Clinical development + NDA review: 9 years NDA review alone: 10 months
average (standard); 6 months (priority review) Historical (pre-PDUFA):
21-29 months for NDA review Note: "10 years" is accurate for total
development timeline (10-15 year range). Modern FDA review is faster (10
months) thanks to PDUFA, but overall timeline remains 12-15 years
Additional sources: https://www.drugs.com/fda-approval-process.html |
https://www.fdareview.org/issues/the-drug-development-and-approval-process/
| https://pmc.ncbi.nlm.nih.gov/articles/PMC6113340/
.76.
CNN. FDA delay in approving rapid COVID-19
tests. CNN: How Government Delayed Testing https://www.cnn.com/2020/04/09/politics/coronavirus-testing-cdc-fda-red-tape-invs/index.html
(2020)
Feb 16, 2020: Seattle research lab
ordered to stop COVID testing without FDA approval May 2020: Gates
Foundation partnership instructed to discontinue testing until
authorization Feb 29, 2020: U. Nebraska finally got FDA permission after
Feb 4 special permission Timeline: Critical delays measured in
weeks-to-months (Feb-March 2020), not specific "6 months FDA guidance
suggested EUAs needed for laboratory-developed tests (LDTs), causing
delays By May 2020: 400+ test applications awaiting FDA review Note:
Delays were weeks-to-months during critical Feb-March 2020 period, not
continuous "6 months." FDA intervention added minimal value while
contributing to deadly delays Additional sources:
https://www.cnn.com/2020/04/09/politics/coronavirus-testing-cdc-fda-red-tape-invs/index.html
|
https://www.yalelawjournal.org/forum/deadly-delay-the-fdas-role-in-americas-covid-testing-debacle
| https://oig.hhs.gov/oei/reports/OEI-01-20-00380.asp
.77.
CRS. Evidence of FDA regulatory capture by
pharmaceutical industry. CRS: FDA Human Medical Product User
Fees https://www.congress.gov/crs-product/R44750
FY2023: User fees = 75% of PDUFA program costs
(vs 7% in FY1993) FY2022: User fees = 66% ($1.4B) of human drugs program
budget FY2022: User fees = 46% ($2.9B) of FDA’s total $6.2B budget
Pharma finances 75% of FDA’s drug division (New York Times) Concerns:
Budgetary dependence, urgency of PDUFA reauthorizations, required
industry participation in negotiations Most PDUFA policy changes favor
industry: decreased regulatory standards, shorter approval times,
increased industry involvement FDA maintains decisions based on science,
not fee collection ability Note: Regulatory capture concerns
well-documented. Industry funding grew from 7% (1993) to 75% (2023) of
drug review program. No evidence found for "10x government salary" claim
for FDA reviewers Additional sources:
https://www.congress.gov/crs-product/R44750 |
https://aspe.hhs.gov/sites/default/files/documents/e4a7910607c0dd76c40aa61151d154f9/FDA-User-Fee-Issue-Brief.pdf
| https://pmc.ncbi.nlm.nih.gov/articles/PMC8917050/
.78.
Wikipedia. Number of key FDA drug reviewers.
Wikipedia: Center for Drug Evaluation and Research https://en.wikipedia.org/wiki/Center_for_Drug_Evaluation_and_Research
CDER review teams: 1,300 employees evaluate and
approve new drugs CDER safety team: 72 employees monitor 3,000+
prescription drugs for 200 million people ($15M/year budget) FDA
Advisory Committees (all 3 centers): 300 individuals serve on 40
committees Advisory committees stable in recent years Note: " 200" may
refer to advisory committee members ( 300 actual) or be approximation.
CDER has 1,300 review staff total. Safety monitoring: 72 people for 200M
patients Additional sources:
https://en.wikipedia.org/wiki/Center_for_Drug_Evaluation_and_Research |
https://www.ncbi.nlm.nih.gov/books/NBK236088/
.79.
FDA. FDA clinical trial launch timeline.
FDA: IND Application Procedures https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview
(2012)
IND application: FDA has 30 days to
object or allow trials to begin NDA/BLA preparation after Phase 3: 6-12
months to assemble safety/effectiveness data Standard NDA review: 10-12
months median (standard review) Priority review: 6 months (vs 10 months
standard) Overall development (first human testing to approval): 12-15
years full timeline Expedited programs: 7.1 years median vs 8.0 years
nonexpedited Note: "6-12 months" likely refers to NDA/BLA preparation
time post-Phase 3, not total trial launch timeline. IND review: 30 days.
Full approval timeline: 10-15 years Additional sources:
https://www.fda.gov/drugs/investigational-new-drug-ind-application/ind-application-procedures-overview
| https://www.drugs.com/fda-approval-process.html |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5820715/
.80.
FDA. FDA trial patient exclusion criteria.
FDA: Evaluating Inclusion & Exclusion Criteria https://www.fda.gov/media/134754/download
Most frequent exclusions: Pregnancy,
lactation/breastfeeding, renal/hepatic abnormalities, specific
infectious diseases Pregnant/lactating women: >90% of trials exclude
Older adults: 27% exclude based on age (arbitrary upper limits)
Patients with organ dysfunction: Excluded due to adverse impact concerns
from comorbidities/concomitant meds Multiple chronic conditions: Often
exclusion criterion despite being common in target population
Children/adolescents: Excluded due to ethical considerations High-risk
patients: Prior malignancy history, active brain metastases, suboptimal
hepatic/renal function, HIV+ FDA guidance: Working to broaden
eligibility; "exclusions based on age alone rarely appropriate Note:
Exclusion criteria often eliminate patients who would actually use the
drug, reducing real-world applicability of trial results Additional
sources: https://www.fda.gov/media/134754/download |
https://www.sciencedirect.com/science/article/abs/pii/S1551714421002512
| https://ascopubs.org/doi/10.1200/EDBK_155880
.81.
PMC. Paperwork comparison between FDA trials
and RECOVERY trial. PMC: Making Trials Part of Good Clinical Care -
RECOVERY https://pmc.ncbi.nlm.nih.gov/articles/PMC8285150/
RECOVERY trial paperwork: One-page consent form,
one-page case report form, single follow-up form Randomisation form:
Simple, collecting few baseline characteristics and ensuring eligibility
Follow-up: Single form completed at earliest of discharge, death, or 28
days Eligibility criteria: Simple; trial processes (including paperwork)
minimized Philosophy: "Avoid additional burden on busy clinicians, so
trial procedures streamlined as far as possible FDA Form 1572: Statement
of Investigator form required for IND trials (specific form, not total
page count) Note: Specific "1,572 pages vs 24 pages" comparison not
found in sources. RECOVERY used 1-page forms. FDA Form 1572 is a
specific required form, not total paperwork count. RECOVERY’s
streamlined approach demonstrated feasibility of simplified trial
documentation Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC8285150/ |
https://pmc.ncbi.nlm.nih.gov/articles/PMC9293394/ |
https://www.fda.gov/media/71816/download
.82.
Commission, F. E. FEC foreign nationals
guidance. Federal Election Commission https://www.fec.gov/updates/foreign-nationals/
The Federal Election Campaign Act (FECA)
prohibits any foreign national from contributing, donating or spending
funds in connection with any federal, state or local election in the
United States, either directly or indirectly. Additional sources:
https://www.fec.gov/updates/foreign-nationals/
.83.
Service, U. E. R. Food abundance in modern
society. USDA Economic Research Service https://www.ers.usda.gov/data-products/food-availability-per-capita-data-system/
(2019)
The average American has access to
approximately 3,800 calories per day in the food supply, nearly double
the recommended daily intake. Additional sources:
https://www.ers.usda.gov/data-products/food-availability-per-capita-data-system/
.84.
Ford, &. N., I. Pragmatic clinical trials -
ALLHAT evidence. Ford https://www.nejm.org/doi/full/10.1056/NEJMra1510059
(2016)
Pragmatic trials are designed to
determine the effects of an intervention under the usual conditions in
which it will be applied. The ALLHAT trial (Antihypertensive and
Lipid-Lowering Treatment to Prevent Heart Attack Trial) demonstrated
that pragmatic designs can identify superior treatments while reducing
healthcare costs by billions annually.
85.
IMF. Fossil fuel subsidies ($7T, 2022).
IMF https://www.imf.org/en/Blogs/Articles/2023/08/24/fossil-fuel-subsidies-surged-to-record-7-trillion
(2023).
86.
Post, W. Deaths from furniture accidents
compared to terrorism. Washington Post: More Likely Crushed by
Furniture https://www.washingtonpost.com/news/monkey-cage/wp/2015/11/23/youre-more-likely-to-be-fatally-crushed-by-furniture-than-killed-by-a-terrorist/
(2015)
Since 9/11/2001: Americans no more
likely to die from terrorism than being crushed by unstable
TVs/furniture Furniture tip-over fatalities (2000-present): 581 total; 4
in 5 deaths were children 2013-2023: 217 reported tip-over fatalities
(23% TV, 25% TV+furniture, 46% furniture only, 7% appliance) Comparison:
Even in Israel (intensive terror campaign), weekly terror casualties
almost never match traffic deaths US terrorism: Deaths so low they
barely register on graphs except 9/11/2001 Note: Post-9/11, furniture
tip-overs have caused comparable/greater fatalities than terrorism for
Americans. Highlights media attention vs actual risk disparity
Additional sources:
https://www.washingtonpost.com/news/monkey-cage/wp/2015/11/23/youre-more-likely-to-be-fatally-crushed-by-furniture-than-killed-by-a-terrorist/
|
https://www.cpsc.gov/s3fs-public/2023_Annual_Tip_Over_Report_Posted_2024Feb_FINAL_0.pdf
|
https://ourworldindata.org/is-it-fair-to-compare-terrorism-and-disaster-with-other-causes-of-death
.87.
Foundation, G. Gates foundation endowment size.
Gates Foundation: Fact Sheet https://www.gatesfoundation.org/about/foundation-fact-sheet
(2024)
Current (July 31, 2025): $86 billion
(unaudited); Dec 31, 2024: $77.2 billion 2022: $70 billion (with new
gifts added) Total contributions: Bill & Melinda Gates $60.2B
(inception-2024); Warren Buffett $43.3B (2006-2024) Structure: Gates
Foundation Trust manages endowment; Gates Foundation conducts
operations/grantmaking World’s largest private philanthropic foundation
Intent: Spend endowment "down to zero" within 20 years of Bill &
Melinda’s deaths Annual payout (2026): $9B/year (50% increase announced
2022) Note: $70B figure accurate for 2022. Endowment has since grown to
$86B (July 2025). Dramatic growth from major contributions by Gates +
Buffett Additional sources:
https://www.gatesfoundation.org/about/foundation-fact-sheet |
https://fortune.com/2024/01/25/bill-gates-foundation-annual-letter-elite-universities-chuck-feeney/
.88.
9(1), G. A. GDPR biometric data requirements.
GDPR Article 9(1) https://gdpr-info.eu/art-9-gdpr/
Processing of biometric data for the purpose of
uniquely identifying a natural person shall be prohibited unless one of
the conditions referred to in points (a) to (j) of paragraph 2 applies.
Additional sources: https://gdpr-info.eu/art-9-gdpr/
.89.
FDA. Generic drug substitution savings.
FDA https://www.fda.gov/drugs/generic-drugs/generic-drug-facts.
90.
FEE. Patients and doctors vs FDA. FEE:
Patients and Doctors vs FDA https://fee.org/articles/patients-and-doctors-vs-the-fda
Dale Gieringer (1985): 21,000-120,000 lives lost
per decade from FDA delay Gieringer: "Loss of life from delay alone in
the hundreds of thousands" (not millions) Beta-blockers alone: William
Wardell estimated "10,000 lives/year" if allowed; FDA delay 1965-1976
Sam Peltzman: Post-1962 death toll from regulatory delay "easily number
in thousands per year Practolol (beta-blocker): "Could save 10,000
lives/year" (Wardell estimate) FDA allowed propranolol 1968 (3 years
after Europe); for hypertension/angina not until 1978 Note: "4-10
million" figure not found in sources. Gieringer’s estimates: 21K-120K
deaths per decade, "hundreds of thousands" total (not millions).
Specific drug delays (beta-blockers): 100K deaths estimated Additional
sources: https://fee.org/articles/patients-and-doctors-vs-the-fda |
https://www.econlib.org/library/Enc/DrugLag.html |
https://www.fdareview.org/issues/theory-evidence-and-examples-of-fda-harm/
.91.
Gitcoin. Gitcoin passport for digital identity
scoring. Gitcoin: Intro to Passport https://www.gitcoin.co/blog/intro-to-passport
Now: Human Passport (acquired by human.tech late
2024); >2M users Purpose: Sybil resistance solution for web3,
privacy-preserving identity verification How it works: "Stamps" from
web2/web3 identifiers (Twitter, Google, BrightID, Proof of Humanity)
aggregated into unique identity score Scoring: Weights based on "cost of
forgery" and ability to signal unique humanity Privacy: Verifiable
credentials check identity without viewing PII Customizable: Communities
create custom "entry visa" with participation requirements Use cases:
Governance voting, gaming, airdrops, bot prevention Gitcoin Grants Round
15: 35,000+ donors created Passports; limited Sybil activity, ensured
fair fund distribution Note: Leading web3 identity/Sybil resistance
tool. Now operates as Human Passport after acquisition. Proven at scale
with millions of users Additional sources:
https://www.gitcoin.co/blog/intro-to-passport |
https://passport.human.tech/ |
https://www.gitcoin.co/blog/cost-of-forgery
.92.
Data, O. W. in. Global armed forces size and
average salary. Our World in Data: Military Personnel &
Spending https://ourworldindata.org/military-personnel-spending
(2024)
Largest forces: China (2.0M active),
India (1.4M), Russia (1.3M active, 3.5M total), US (1.3M active) Global
military spending 2024: US $1T (next 12 countries combined); NATO 32
members: $1.5T (55% of world) Military spending per personnel: Tracked
by SIPRI, World Bank (includes personnel, O&M, procurement, R&D,
infrastructure, aid) Average varies widely: US military much higher
per-personnel spending than most countries Note: Specific "28.4M global
armed forces" and "$24,000 average salary" not confirmed in sources.
Data available but highly variable by country. Major forces total 10M+
personnel among largest militaries Additional sources:
https://ourworldindata.org/military-personnel-spending |
https://data.worldbank.org/indicator/MS.MIL.TOTL.P1 |
https://www.sipri.org/sites/default/files/2025-04/2504_fs_milex_2024.pdf
.93.
ScienceDaily. Global burden of disease study
2013: 2.4 billion people with chronic diseases. ScienceDaily: GBD
2013 Study https://www.sciencedaily.com/releases/2015/06/150608081753.htm
(2013)
The Global Burden of Disease Study
2013 found that 2.3 billion people worldwide were experiencing five or
more chronic ailments, with only 4.3% of the global population having no
health problems. Eight chronic disorders affected more than 10% of the
world population in 2013, including cavities in permanent teeth (2.4
billion), tension-type headaches (1.6 billion), iron-deficiency anemia
(1.2 billion), age-related hearing loss (1.23 billion), and migraine
(850 million). As of 2020-2021: cardiovascular disease affects 523
million people, diabetes affects 537 million, and NCDs account for 41
million deaths annually (74% of all deaths). Additional sources:
https://www.sciencedaily.com/releases/2015/06/150608081753.htm |
https://news.un.org/en/story/2023/05/1136832 |
https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases
| https://pmc.ncbi.nlm.nih.gov/articles/PMC10830426/
.94.
Conversation, T. Global cancer research
spending ( $51.4B, 2016-2023). The Conversation https://theconversation.com/billions-spent-on-cancer-research-globally-but-is-it-money-well-spent-201407
(2023).
95.
Fund, T. G. The global fund. The Global
Fund https://www.theglobalfund.org/en/about-the-global-fund/.
96.
Fund, G. Lives saved by the global fund.
Global Fund: Results Report 2025 https://www.theglobalfund.org/en/results/
(2025)
2025: 70 million lives saved (current
figure) Oct 2024: 65 million lives saved Sep 2022: 50 million lives
saved over 20 years Death rate reduction: 63% combined death rate from
AIDS, TB, malaria (61% since 2002) Since inception (2002): Partnership
saved 70M lives fighting HIV, TB, malaria across 100+ countries Note:
50M was Sept 2022 figure. Current (2025): 70M lives saved. One of
world’s most effective global health partnerships Additional sources:
https://www.theglobalfund.org/en/results/ |
https://www.theglobalfund.org/en/news/2022/2022-09-12-new-global-fund-report-shows-50-million-lives-saved-over-20-years-in-fight-against-hiv-tb-malaria/
.97.
Statista. Global GDP ($101T, 2022).
Statista https://www.statista.com/statistics/268750/global-gross-domestic-product-gdp/
(2023)
The global economy is projected to
grow from about 101 trillion U.S. dollars in 2022 to about 139 trillion
U.S. dollars in 2027. Additional sources:
https://www.statista.com/statistics/268750/global-gross-domestic-product-gdp/
.98.
Bank, W. Global GDP in 2023 ($89.5 trillion).
World Bank https://data.worldbank.org/indicator/NY.GDP.MKTP.CD
(2023).
99.
budgets:, S. component country. Global
government medical research spending ($67.5B, 2023–2024). See
component country budgets: NIH Budget #nih-budget-fy2025.
100.
Organization, W. H. Global health spending as a
share of GDP (9.8%, 2020). World Health Organization https://www.who.int/publications/i/item/9789240064929
(2022).
101.
Wikipedia. Number of major global military
facilities (4,435). Wikipedia: List of American Military
Installations https://en.wikipedia.org/wiki/List_of_American_military_installations
US military bases worldwide: 750-877 (varies by
source/definition) Conservative count: 128 military bases in 55
countries/territories (Feb 2025) Broader count: 750+ bases in 80+
countries; some sources cite 877 Large bases (>4 hectares or
>$10M, >200 personnel): 439 (60% of US foreign bases) Small
bases/"Lily Pads" (<4 hectares or <$10M): Remaining 40% Other
nations: At least 18 other nations operate foreign military bases; NATO
countries (France, UK): +200 locations Note: "4,435" not found in
sources. US operates 750-877 bases overseas. May include domestic + all
nations’ bases combined, but specific figure not verified Additional
sources:
https://en.wikipedia.org/wiki/List_of_American_military_installations |
https://www.visualcapitalist.com/mapped-every-known-u-s-military-base-overseas/
| https://worldbeyondwar.org/military-empires/
.102.
SIPRI. Global military spending ($2.72T, 2024).
SIPRI https://www.sipri.org/publications/2025/sipri-fact-sheets/trends-world-military-expenditure-2024
(2025).
103.
C&EN. Annual number of new drugs approved
globally: 50. C&EN https://cen.acs.org/pharmaceuticals/50-new-drugs-received-FDA/103/i2
(2025)
50 new drugs approved annually
Additional sources:
https://cen.acs.org/pharmaceuticals/50-new-drugs-received-FDA/103/i2 |
https://www.fda.gov/drugs/development-approval-process-drugs/novel-drug-approvals-fda
.104.
Report, I. Global trial capacity. IQVIA
Report: Clinical Trial Subjects Number Drops Due to Decline in COVID-19
Enrollment https://gmdpacademy.org/news/iqvia-report-clinical-trial-subjects-number-drops-due-to-decline-in-covid-19-enrollment/
1.9M participants annually (2022, post-COVID
normalization from 4M peak in 2021) Additional sources:
https://gmdpacademy.org/news/iqvia-report-clinical-trial-subjects-number-drops-due-to-decline-in-covid-19-enrollment/
.105.
Talk, A. Grant writing time for top researchers
(50%). Acquisition Talk https://acquisitiontalk.com/2021/12/top-researchers-spend-50-of-their-time-writing-grants-how-to-fix-it-and-what-it-means-for-dod/
(2021)
Top researchers can spend up to 50% of
their time writing grants. Additional sources:
https://acquisitiontalk.com/2021/12/top-researchers-spend-50-of-their-time-writing-grants-how-to-fix-it-and-what-it-means-for-dod/
.106.
PubMed. The nine hallmarks of aging.
PubMed: The Hallmarks of Aging https://pubmed.ncbi.nlm.nih.gov/23746838/
Nine hallmarks of aging (López-Otín et al.,
2013): 1. Genomic instability, 2. Telomere attrition, 3. Epigenetic
alterations, 4. Loss of proteostasis, 5. Deregulated nutrient-sensing,
6. Mitochondrial dysfunction, 7. Cellular senescence, 8. Stem cell
exhaustion, 9. Altered intercellular communication Categories: (a)
Primary hallmarks (unequivocally deleterious: genomic instability,
telomere attrition, epigenetic alterations, loss of proteostasis); (b)
Antagonistic hallmarks (beneficial at low levels, deleterious at high:
deregulated nutrient sensing, cellular senescence, mitochondrial
dysfunction); (c) Integrative hallmarks (affect tissue homeostasis: stem
cell exhaustion, altered intercellular communication) Additional
sources: https://pubmed.ncbi.nlm.nih.gov/23746838/ |
https://www.cell.com/cell/fulltext/S0092-8674(13 |
https://pmc.ncbi.nlm.nih.gov/articles/PMC3836174/ |
https://www.cell.com/cell/fulltext/S0092-8674(20
.107.
Adida et al., H. Helios (end-to-end verifiable
voting). Adida et al. https://heliosvoting.org/
Helios is an open-audit voting system… voters can
verify that their vote is included and correctly tallied. Additional
sources: https://heliosvoting.org/
.108.
Calculator, U. I. Historical healthcare
inflation rate (6.2%). US Inflation Calculator: Health Care
1948-2025 https://www.usinflationcalculator.com/inflation/health-care-inflation-in-the-united-states/
(1948)
Long-term average (1935-2025): 4.59%
annual (per Consumer Price Index for Medical Care, BLS) 2000-2023: 3.5%
average annual medical care cost inflation Medical Care Price Index
(MCPI): 3.7% compound annual growth (past 2 decades) vs 2.6% for
Personal Health Care (PHC) & PCE health indexes Recent (Aug 2025):
3.4% year-over-year health care price increase Additional sources:
https://www.usinflationcalculator.com/inflation/health-care-inflation-in-the-united-states/
| https://www.in2013dollars.com/Medical-care/price-inflation |
https://pmc.ncbi.nlm.nih.gov/articles/PMC5785315/ |
https://ycharts.com/indicators/us_health_care_inflation_rate
.109.
Data, O. W. in. Historical life expectancy
around 30 years. Our World in Data: Life Expectancy https://ourworldindata.org/life-expectancy
(2022)
Average life expectancy at birth: 30
years for most of human history until 1800s 1820: Global average still
30 years; 1800-2000: Rose from 30 to 67 years Context: Low life
expectancy driven primarily by high infant mortality ( 1/3 of children
died before age 5) Medieval England: Life expectancy at birth = 31.3
years, but life expectancy at age 25 = 25.7 additional years (total
50.7) Roman Egypt: Average in 20s, but many lived into 40s+ if they
survived childhood Additional sources:
https://ourworldindata.org/life-expectancy |
https://pmc.ncbi.nlm.nih.gov/articles/PMC2625386/ |
https://sc.edu/uofsc/posts/2022/08/conversation-old-age-is-not-a-modern-phenomenon.php
|
https://www.discovermagazine.com/the-sciences/what-was-the-life-expectancy-of-ancient-humans
.110.
NHGRI. Human genome project and CRISPR
discovery. NHGRI https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp
(2003)
Your DNA is 3 billion base pairs Read
the entire code (Human Genome Project, completed 2003) Learned to edit
it (CRISPR, discovered 2012) Additional sources:
https://www.genome.gov/11006929/2003-release-international-consortium-completes-hgp
|
https://www.nobelprize.org/prizes/chemistry/2020/press-release/
.111.
PMC521. Hypertension screening & treatment
cost per QALY. PMC5217841 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217841/
(7841)
The estimated cost per QALY gained for
screening was less than 1000formenandapproximately1600
for women. Additional sources:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217841/
.112.
ICAN. International campaign to abolish nuclear
weapons (ICAN) - treaty on the prohibition of nuclear weapons (2017).
ICAN https://www.icanw.org/ican_history
(2017)
ICAN: Founded 2007, headquartered in
Geneva, coordinating 468+ partner organizations across 100+ countries
(as of 2017) Staff: 3 full-time + 2 part-time in Geneva office (when
Nobel Prize awarded) Funding: Initial grant from Poola Foundation
(Australia); Norwegian government grant to establish Geneva office
(2011) Treaty on the Prohibition of Nuclear Weapons (TPNW): Adopted July
7, 2017 by vote of 122-1 at UN Achievement: Nobel Peace Prize 2017 "for
its work to draw attention to the catastrophic humanitarian consequences
of any use of nuclear weapons Additional sources:
https://www.icanw.org/ican_history |
https://en.wikipedia.org/wiki/International_Campaign_to_Abolish_Nuclear_Weapons
| https://www.nobelprize.org/prizes/peace/2017/ican/facts/ |
https://www.icanw.org/the_treaty
.113.
ICRC. International campaign to ban landmines
(ICBL) - ottawa treaty (1997). ICRC https://www.icrc.org/en/doc/resources/documents/article/other/57jpjn.htm
(1997)
ICBL: Founded 1992 by 6 NGOs (Handicap
International, Human Rights Watch, Medico International, Mines Advisory
Group, Physicians for Human Rights, Vietnam Veterans of America
Foundation) Started with ONE staff member: Jody Williams as founding
coordinator Grew to 1,000+ organizations in 60 countries by 1997 Ottawa
Process: 14 months (October 1996 - December 1997) Convention signed by
122 states on December 3, 1997; entered into force March 1, 1999
Achievement: Nobel Peace Prize 1997 (shared by ICBL and Jody Williams)
Government funding context: Canada established $100M CAD Canadian
Landmine Fund over 10 years (1997); International donors provided $169M
in 1997 for mine action (up from $100M in 1996) Additional sources:
https://www.icrc.org/en/doc/resources/documents/article/other/57jpjn.htm
| https://en.wikipedia.org/wiki/International_Campaign_to_Ban_Landmines
| https://www.nobelprize.org/prizes/peace/1997/summary/ |
https://un.org/press/en/1999/19990520.MINES.BRF.html |
https://www.the-monitor.org/en-gb/reports/2003/landmine-monitor-2003/mine-action-funding.aspx
.114.
ID.me. ID.me digital identity verification
service. ID.me: Government Services https://www.id.me/individuals/government
Trusted technology partner to multiple US
government agencies for secure digital identity verification Scale:
Serves 20 federal agencies, 44 state government agencies, 66 healthcare
organizations Use cases: Unemployment, Tax, Retirement, Centers for
Medicare/Medicaid 2013: Awarded 2-year grant by US Chamber for
President’s National Strategy for Trusted Identities in Cyberspace
(NSTIC) 2014: Won contract with General Services Administration for
Connect.gov digital identity credentials COVID-19 pandemic: Contracted
by several state unemployment agencies to verify claimants Standards:
NIST 800-63-3 establishes guidelines for identity verification providers
serving federal agencies Privacy concerns: IRS announced (Feb 2022) new
authentication option without biometric data including facial
recognition Additional sources: https://www.id.me/individuals/government
| https://en.wikipedia.org/wiki/ID.me | https://www.id.me/about |
https://www.id.me/business/government
.115.
Health Metrics, I. for & (IHME), E. IHME
global burden of disease (2.55B DALYs, 2019). Institute for Health
Metrics and Evaluation (IHME) https://vizhub.healthdata.org/gbd-compare/
(2020)
Globally, in 2019, the total number of
DALYs from all causes was 2.55 billion. Additional sources:
https://vizhub.healthdata.org/gbd-compare/ |
https://www.healthdata.org/research-analysis/about-gbd |
https://pubmed.ncbi.nlm.nih.gov/33069326/
.116.
Illinois, A. Illinois biometric information
privacy act (BIPA). ACLU Illinois: BIPA https://www.aclu-il.org/en/campaigns/biometric-information-privacy-act-bipa
Enacted: October 3, 2008 (introduced Feb 14, 2008
by State Sen. Terry Link; passed both Houses July 10, 2008; signed by
Gov. Rod Blagojevich) Purpose: Regulate collection, use, and handling of
biometric identifiers and information by private entities in Illinois
Requirements: Written notice of what data is collected/stored, specific
purpose & duration, obtain written consent Covered biometrics:
Retina/iris scans, fingerprints, voiceprints, hand scans, facial
geometry, DNA, other unique biological info Prohibitions: Selling or
profiting from consumers’ biometric information Penalties: $1,000 per
violation; $5,000 per intentional/reckless violation Private right of
action: Any aggrieved individual can sue 2024 update (SB2979): Multiple
collections from same person = single violation (single recovery per
individual) Additional sources:
https://www.aclu-il.org/en/campaigns/biometric-information-privacy-act-bipa
| https://en.wikipedia.org/wiki/Biometric_Information_Privacy_Act |
https://securiti.ai/privacy-laws/us/illinois/ |
https://www.winston.com/en/legal-glossary/what-is-bipa
.117.
PMC. Indian aadhaar national identity system.
PMC: Aadhaar Failure to Do No Harm https://pmc.ncbi.nlm.nih.gov/articles/PMC5741784/
Largest biometric identity system in history: 1
billion registered users (nearly all of India’s 1.4B population)
12-digit unique identification number issued by Unique Identification
Authority of India (UIDAI) Biometric data: Fingerprints, facial images,
iris scans stored in Central Identities Repository (national centralized
database) Privacy concerns: Deployed without direct legislative
privacy/ethics constraints; comprehensive data protection legislation
not yet passed Security issues: High-ranking official’s Aadhaar number
shared on Twitter led to hackers accessing personal info (mobile, tax
ID) 2017: Supreme Court enshrined privacy rights Supreme Court ruling: 4
of 5 judges allowed program to continue with limited scope &
restrictions on data storage Threats: Potential for 360-degree
profiling; viewed by many as mass surveillance tool infringing privacy
rights Note: "with privacy protections" is questionable - significant
privacy concerns remain despite Supreme Court restrictions Additional
sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC5741784/ |
https://time.com/5388257/india-aadhaar-biometric-identification/ |
https://privacyinternational.org/case-study/4698/id-systems-analysed-aadhaar
|
https://insights.som.yale.edu/insights/what-happens-when-billion-identities-are-digitized
.118.
size, D. from global market & ratios,
public/private funding. Private industry clinical trial spending.
Private pharmaceutical and biotech industry
spends approximately $75-90 billion annually on clinical trials,
representing roughly 90% of global clinical trial
spending.
119.
Snopes. History of insulin patent and modern
price disparities. Snopes: Insulin Patent Dollar https://www.snopes.com/fact-check/insulin-patent-dollar/
(2019)
1923: Frederick Banting, Charles Best,
James Collip sold insulin patent to U. of Toronto for $1 each (total $3)
Banting: Unethical for doctor to profit from life-saving discovery;
wanted everyone to afford it Manufacturing cost: $6 per vial US retail
price: $300-332 per vial (Humalog: $21 in 1999 → $332 in 2019 = 1,000%+
increase) Price increases: 600% over 20 years; 200% between 2007-2018
Patients without insurance: Up to $1,000/month Contributing factors:
Patent evergreening, barriers to biosimilar entry, market concentration
(Eli Lilly, Novo Nordisk, Sanofi) Additional sources:
https://www.snopes.com/fact-check/insulin-patent-dollar/ |
https://www.t1international.com/100years/ |
https://pnhp.org/news/why-insulin-is-overpriced/ |
https://www.npr.org/2019/06/18/733742630/desperate-measures-the-skyrocketing-price-of-insulin-in-america
.120.
Info, U. G. Intelligence spending as percentage
of military budgets. US Government Info: Cost of Intelligence
https://www.govinfo.gov/content/pkg/GPO-INTELLIGENCE/html/int017.html
US: Military-related budget lines (DoE, State
Dept, National Intelligence Program) = 11% of US spending (2024)
Intelligence funding: Grew faster than military when military spending
increased; decreased slower when military spending decreased Historical
trend: Intelligence funding reached level 80% above 1980 baseline US
National Intelligence Program + Military Intelligence Program ≈ 10-11%
of total military-related spending Additional sources:
https://www.govinfo.gov/content/pkg/GPO-INTELLIGENCE/html/int017.html |
https://sgp.fas.org/crs/intel/R44381.pdf |
https://en.wikipedia.org/wiki/United_States_intelligence_budget
.121.
Statista. Number of global internet users.
Statista: Internet Users Worldwide 2024 https://www.statista.com/statistics/273018/number-of-internet-users-worldwide/
(2024)
2022: Surpassed 5 billion users
worldwide 2024 (Oct): 5.52 billion (67.5% of global population);
year-end: 5.5B 2025 (start): 5.560 billion (67.9% of population); Oct
2025: 6.04 billion (73.2% of population) Growth: +136M in 2024 (+2.5%),
+294M over 12 months to Oct 2025 (+5.1%) Still disconnected: 2.630
billion people at start of 2025 Additional sources:
https://www.statista.com/statistics/273018/number-of-internet-users-worldwide/
|
https://www.digitalinformationworld.com/2025/02/global-internet-users-surpass-offline-556-billion-2025.html
| https://datareportal.com/global-digital-overview |
https://www.sganalytics.com/blog/global-internet-usage-statistics/
.122.
Wikipedia. Journal of the american medical
association (JAMA) founded in 1883. Wikipedia: JAMA https://en.wikipedia.org/wiki/JAMA
Founded: 1883 by American Medical Association
Founding editor: Nathan Smith Davis Superseded: Transactions of the
American Medical Association 1960: Obtained current title "JAMA: The
Journal of the American Medical Association Evolution: Late 1800s
resembled general journalism; 1910s-1920s "turndown era" began rejecting
submissions based on quality; routine peer review instituted after WWII
Current: Peer-reviewed medical journal published 48 times/year covering
all aspects of biomedicine Additional sources:
https://en.wikipedia.org/wiki/JAMA |
https://jamanetwork.com/journals/jama/fullarticle/291201 |
https://onlinebooks.library.upenn.edu/webbin/serial?id=jama
.123.
Prize, N. James buchanan nobel prize in
economics, 1986. Nobel Prize: 1986 Economic Sciences https://www.nobelprize.org/prizes/economic-sciences/1986/press-release/
(1986)
James McGill Buchanan: 1986 Nobel
Memorial Prize in Economic Sciences Citation: "for his development of
the contractual and constitutional bases for the theory of economic and
political decision-making Field: Public choice theory (leading
researcher & cofounder with Gordon Tullock) Key work: "The Calculus
of Consent" (with Tullock) - now considered a classic, started the field
Contribution: Transferred concept of gain from mutual exchange between
individuals to political decision-making; applied economic analysis to
public sector Inspiration: Swedish economist Knut Wicksell (described as
"most exciting intellectual moment" of career) Additional sources:
https://www.nobelprize.org/prizes/economic-sciences/1986/press-release/
| https://en.wikipedia.org/wiki/James_M._Buchanan |
https://www.britannica.com/money/James-M-Buchanan |
https://www.econlib.org/library/Enc/bios/Buchanan.html
.124.
FDLI. Japan’s regenerative medicine act and
conditional approval pathway. FDLI: Japan’s Regen Med Pathways
https://www.fdli.org/2019/02/global-focus-japans-regenerative-medicine-regulatory-pathways-encouraging-innovation-and-patient-access/
(2019)
Act on Safety of Regenerative Medicine
(RM Act) + amended Pharmaceuticals and Medical Devices Act (PMD Act):
passed Nov 2013, effective Nov 2014 Conditional and time-limited
approval pathway: Obtain approval after exploratory trials demonstrate
probable benefit and proven safety 7-year conditional approval period to
confirm clinical benefit (e.g., using surrogate endpoints) SAKIGAKE
designation (April 2015): Expedited pathway for innovative products
targeting serious/life-threatening diseases without effective treatment
Benefits: Prioritized consultation, accelerated review, extended
re-examination period, premium pricing Examples: Terumo’s HeartSheet and
Stemirac obtained conditional approval; Stemirac also
SAKIGAKE-designated Additional sources:
https://www.fdli.org/2019/02/global-focus-japans-regenerative-medicine-regulatory-pathways-encouraging-innovation-and-patient-access/
|
https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/310/Experiences-from-Japan-SAKIGAKE-Designation-System-for-Regenerative-Medical-Products
| https://pmc.ncbi.nlm.nih.gov/articles/PMC6696404/
.125.
GovTrack. Kefauver harris amendment of 1962.
GovTrack https://www.govtrack.us/congress/bills/87/s1552
(1962)
regulating efficacy testing via the
1962 Kefauver Harris Amendment. The 1962 regulations made these large
real-world efficacy trials illegal. Additional sources:
https://www.govtrack.us/congress/bills/87/s1552 |
https://www.fda.gov/about-fda/histories-product-regulation/promoting-safe-effective-drugs-100-years
| https://pmc.ncbi.nlm.nih.gov/articles/PMC4101807/
.126.
Foundation, N. K. Annual deaths from kidney
disease. National Kidney Foundation: Global Facts https://www.kidney.org/global-facts-about-kidney-disease
(2022)
Direct CKD deaths: 1.2M (2017), 1.53M
(2021); increased from 591,800 (1990) to 1,425,670 (2019)
CKD-attributable cardiovascular deaths: Additional 1.4M deaths from CVD
attributable to impaired kidney function (7.6% of all CVD deaths, 2017)
Combined impact: 4.6% of total global mortality CKD: 12th leading cause
of death globally; one of few NCDs showing increased deaths over past 2
decades Additional sources:
https://www.kidney.org/global-facts-about-kidney-disease |
https://pmc.ncbi.nlm.nih.gov/articles/PMC9073222/ |
https://www.thelancet.com/article/S0140-6736(20 |
https://www.healthdata.org/news-events/newsroom/news-releases/chronic-kidney-disease-global-killer-plain-sight
.127.
Dive, B. Approval of landmark gene therapies
(luxturna, zolgensma, CAR-t). BioPharma Dive: Luxturna https://www.biopharmadive.com/news/luxturna-gene-therapy-eye-leber-lca/609832/
(2017)
Luxturna (Dec 2017): First in vivo
gene therapy approved by US FDA; treats biallelic RPE65
mutation-associated retinal dystrophy (inherited blindness); $850,000
one-time therapy CAR-T therapies (2017): Kymriah and Yescarta approved
same year as Luxturna Zolgensma (May 2019): Spinal muscular atrophy
treatment; second gene therapy for inherited disease in US; $2.1M (one
of most expensive medicines at the time) Described as "landmark moment
for a field riddled with ups and downs" and "landmark achievements in
history of modern science Additional sources:
https://www.biopharmadive.com/news/luxturna-gene-therapy-eye-leber-lca/609832/
|
https://cen.acs.org/articles/95/web/2017/12/First-gene-therapy-genetic-disease.html
|
https://www.npr.org/sections/health-shots/2017/12/19/571962226/first-gene-therapy-for-inherited-disease-gets-fda-approval
| https://pmc.ncbi.nlm.nih.gov/articles/PMC7123914/
.128.
Landray, S. M. Landray, sir martin, on the
RECOVERY trial. Sir Martin Landray https://www.ox.ac.uk/news/features/recovery-trial-two-years
In 2019, I had no idea that I would be setting up
a trial of treatments for an infectious disease, let alone a pandemic
virus. I certainly would not have thought it possible to go from a blank
piece of paper to enrolling the first patient in nine days, to finding
the first life-saving treatment within ten weeks, and for it to be made
standard NHS policy within three hours. Additional sources:
https://www.ox.ac.uk/news/features/recovery-trial-two-years
.129.
CSV, S. U. L. E. F. B. 1543-2019. US
life expectancy growth 1880-1960: 3.82 years per decade. (2019)
Pre-1962: 3.82 years/decade Post-1962: 1.54
years/decade Reduction: 60% decline in life expectancy growth rate
Additional sources: https://ourworldindata.org/life-expectancy |
https://www.mortality.org/ |
https://www.cdc.gov/nchs/nvss/mortality_tables.htm
.130.
Statecraft, R. Lobbying ROI calculation ($1,813
per $1). Responsible Statecraft https://responsiblestatecraft.org/2021/09/02/top-military-firms-see-2t-return-on-1b-investment-in-afghan-war/
(2021).
131.
OpenSecrets. Lobbyist statistics for washington
d.c. OpenSecrets: Lobbying in US https://en.wikipedia.org/wiki/Lobbying_in_the_United_States
Registered lobbyists: Over 12,000 (some
estimates); 12,281 registered (2013) Former government employees as
lobbyists: 2,200+ former federal employees (1998-2004), including 273
former White House staffers, 250 former Congress members & agency
heads Congressional revolving door: 43% (86 of 198) lawmakers who left
1998-2004 became lobbyists; currently 59% leaving to private sector work
for lobbying/consulting firms/trade groups Executive branch: 8% were
registered lobbyists at some point before/after government service
Additional sources:
https://en.wikipedia.org/wiki/Lobbying_in_the_United_States |
https://www.opensecrets.org/revolving-door |
https://www.citizen.org/article/revolving-congress/ |
https://www.propublica.org/article/we-found-a-staggering-281-lobbyists-whove-worked-in-the-trump-administration
.132.
OpenSecrets. Lockheed martin’s political
donations, contracts, and state operations in 2022. OpenSecrets:
Lockheed Martin Summary https://www.opensecrets.org/orgs/lockheed-martin/summary?id=d000000104
(2022)
Political contributions 2022:
$3,946,639 (PAC + individuals); PAC alone: $1,542,500 to federal
candidates (2021-2022 cycle) Lobbying 2022: $13.6M expenditure (focused
on military appropriations, foreign military sales) Geographic
footprint: Operations in over half of states; employs 1,000-20,000+ per
state Additional sources:
https://www.opensecrets.org/orgs/lockheed-martin/summary?id=d000000104 |
https://www.opensecrets.org/political-action-committees-pacs/lockheed-martin/C00303024/candidate-recipients/2022
|
https://www.taxpayer.net/wp-content/uploads/2024/10/Oct-2024-Political-Footprint-of-the-Military-Industry.pdf
.133.
Wikipedia. The collapse of long-term capital
management (LTCM) in 1998. Wikipedia: LTCM https://en.wikipedia.org/wiki/Long-Term_Capital_Management
(2013)
Founded 1994 by John Meriwether
(former Salomon Brothers vice-chairman) Board included Nobel Prize
winners: Myron Scholes & Robert C. Merton (1997 Nobel in Economics
for Black-Scholes model) Initial success: 21% (year 1), 43% (year 2),
41% (year 3) annualized returns after fees 1998 collapse: Lost $4.6B in
<4 months due to high leverage + 1997 Asian crisis + 1998 Russian
crisis Extreme leverage: $30 debt per $1 capital (end of 1997) Bailout:
$3.6B ($3.625B) from 14 banks, brokered by Federal Reserve Bank of NY
(Fed didn’t lend own funds) By early 2000: Fund liquidated, creditors
repaid Additional sources:
https://en.wikipedia.org/wiki/Long-Term_Capital_Management |
https://www.federalreservehistory.org/essays/ltcm-near-failure |
https://www.wallstreetmojo.com/long-term-capital-management/ |
https://blogs.cfainstitute.org/investor/2013/11/04/the-incredible-untold-story-about-how-the-financial-world-almost-ended/
.134.
Numbers, T. by. Lost human capital due to war
($270B annually). Think by Numbers: War Costs $74 <https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/>
(2021)
Lost human capital from war: $300B
annually (economic impact of losing skilled/productive individuals to
conflict) Broader conflict/violence cost: $14T/year globally 1.4M
violent deaths/year; conflict holds back economic development, causes
instability, widens inequality, erodes human capital 2002: 48.4M DALYs
lost from 1.6M violence deaths = $151B economic value (2000 USD)
Economic toll includes: commodity prices, inflation, supply chain
disruption, declining output, lost human capital Additional sources:
<https://thinkbynumbers.org/military/war/the-economic-case-for-peace-a-comprehensive-financial-analysis/>
|
https://www.weforum.org/stories/2021/02/war-violence-costs-each-human-5-a-day/
| https://pubmed.ncbi.nlm.nih.gov/19115548/
.135.
MakerDAO. MakerDAO scale. MakerDAO https://defillama.com/protocol/maker
(2024).
136.
WHO. Annual deaths from malaria. WHO
https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024
(2024)
600,000 people per year die from
malaria (a disease spread by a bug we can’t figure out how to properly
swat) Additional sources:
https://www.who.int/teams/global-malaria-programme/reports/world-malaria-report-2024
.137.
Brookings. Manhattan project cost in modern
dollars. Brookings: Costs of the Manhattan Project https://www.brookings.edu/the-costs-of-the-manhattan-project/
Original cost: $1.89 billion (1945 dollars)
Inflation-adjusted: $29.6-32.9 billion (2023-2024 dollars) Almost
two-thirds of budget spent on Oak Ridge uranium enrichment facilities
Note: Los Alamos received just 4% of total budget. For comparison, the
B-29 bomber program was more expensive than the Manhattan Project
Additional sources:
https://www.brookings.edu/the-costs-of-the-manhattan-project/ |
https://moneyzine.com/how-much-did-the-manhattan-project-cost/
.138.
Wikipedia. Pharmaceutical lobby influence on
medicare modernization act of 2003. Wikipedia: Medicare
Modernization Act https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,_Improvement,_and_Modernization_Act
Medicare Prescription Drug, Improvement, and
Modernization Act (P.L. 108-173): Signed Dec 8, 2003 by President Bush;
created voluntary Part D prescription drug benefit Noninterference
provision": Prohibits HHS Secretary from negotiating drug prices or
establishing preferred drug list Instead: Drug prices negotiated between
manufacturers & insurance companies administering Part D plans
Pharma industry role in writing: "Noninterference clause" written with
major industry involvement; drug manufacturers had major role writing
& getting it through Congress Industry lobbying: $231M spent on
lobbying in 2003 (more than any other industry since 1998) Rep. Billy
Tauzin example: 2004 appointed PhRMA chief lobbyist ($2M/year rumored);
responsible for including price negotiation prohibition 2022 change:
Inflation Reduction Act removed ban; Medicare can negotiate starting
2026 Additional sources:
https://en.wikipedia.org/wiki/Medicare_Prescription_Drug,_Improvement,_and_Modernization_Act
|
https://www.healthaffairs.org/content/forefront/politics-medicare-and-drug-price-negotiation-updated
|
https://www.congress.gov/crs-products/product/pdf/R/R47872
.139.
Wikipedia. Michael milken and the development
of the high-yield bond market. Wikipedia: Michael Milken https://en.wikipedia.org/wiki/Michael_Milken
Michael Milken ("Junk Bond King"): Pioneered
high-yield "junk bond" market with Drexel Burnham Lambert (1970s-1980s)
Original-issue high-yield debt innovation provided hostile bidders &
LBO firms enormous capital for multi-billion-dollar deals Mid-1980s:
Milken’s high-yield bond buyer network enabled rapid large-scale
fundraising, facilitated LBOs (e.g., KKR) Market growth: End of 1980s =
$150B junk-bond market; Drexel became leading US financial firm with
50% market share Milken compensation: >$1B over 4 years (late 1980s)
- US income record at the time 1989: Indicted for
racketeering/securities fraud; plea bargain to securities/reporting
violations (not racketeering/insider trading) 1990: Drexel bankruptcy
& liquidation Additional sources:
https://en.wikipedia.org/wiki/Michael_Milken |
https://www.hbs.edu/faculty/Pages/item.aspx?num=50852 |
https://www.britannica.com/money/Michael-R-Milken |
https://www.sechistorical.org/museum/galleries/wwr/wwr05d-markets-milken.php
.140.
USAFacts. NATO o&m ratios for global
spending. USAFacts: US Military Spending https://usafacts.org/articles/how-much-does-the-us-spend-on-the-military/
(2024)
Operations & Maintenance
(O&M): 38-50% of military spending US FY2024: O&M cost $332B
(38% of military spending), up from 28% in 1974 2005-2015 trend: O&M
represented 40-50% of DoD total budget NATO 2024: $1.47T total spending
across 32 member countries; US $967B (66%), European members $454B (30%)
NATO equipment investment guideline: At least 20% of military
expenditures for major equipment/R&D Additional sources:
https://usafacts.org/articles/how-much-does-the-us-spend-on-the-military/
| https://www.cbo.gov/publication/52156 |
https://www.nato.int/cps/en/natohq/topics_49198.htm |
https://www.statista.com/statistics/1293301/combined-military-expenditures-nato/
.141.
Us, A. of. NIH all of us research program
outcomes and spending. All of Us: Program Overview https://allofus.nih.gov/article/program-overview
(2026)
Total authorized funding: $2.16B (not
$4B) - $1.02B allocated since 2015, $1.14B authorized through 2026 via
21st Century Cures Act Budget cut 71% over 2 years: $500M+ (2023) →
$150M (2025) Enrolled: 860,000 participants from all 50 states; 633,000+
participants with data available for research Clinical trials completed:
Zero (program is observational cohort study, not a clinical trial
program) Purpose: Collect prospective data to inform future clinical
trials, provide recruitment infrastructure Additional sources:
https://allofus.nih.gov/article/program-overview |
https://www.nejm.org/doi/full/10.1056/NEJMsr1809937 |
https://www.genomeweb.com/sequencing/all-us-research-program-unfazed-funding-cuts-lays-out-plans-through-2026
.142.
NSF. Annual number of papers published from
NIH-funded research. NSF: Publications Output https://ncses.nsf.gov/pubs/nsb20206
Global scientific output: 2.5-2.6 million
research papers published annually (all sources, not just NIH) Worldwide
S&E publication growth: 1.8M (2008) → 2.6M articles (2018),
averaging 4% annual growth NIH-specific output example (2000): 4,451
R01 grants ($1.3B) produced 55,000 publications, 3.7M citations Total
active journals: 46,736 peer-reviewed journals (2020) publishing 3M+
articles annually Additional sources:
https://ncses.nsf.gov/pubs/nsb20206 |
https://ourworldindata.org/grapher/scientific-publications-per-million |
https://pmc.ncbi.nlm.nih.gov/articles/PMC8738817/
.143.
Forum, J. H. NIH actual interventional trial
spending: Only 3.3% of budget. JAMA Health Forum: NIH Clinical
Development Spending (2023) https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/
(2023)
The "33% clinical research" category
is misleading. NIH spent only **$8.1 billion (3.3% of $247.3 billion)**
on phased clinical development (Phases 1-3) for drugs approved
2010-2019. This represents just ** 10% of what industry spends** on
clinical trials. The remaining "clinical research" budget includes
observational studies, epidemiological research, health services
research, and infrastructure—not actual interventional trials testing
treatments. Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC10349341/ |
https://catalyst.harvard.edu/news/article/nih-spent-8-1b-for-phased-clinical-trials-of-drugs-approved-2010-19-10-of-reported-industry-spending/
.144.
PMC. Number of diseases eradicated by the NIH.
PMC: Six Challenges in Eradication https://pmc.ncbi.nlm.nih.gov/articles/PMC7612385/
Diseases eradicated globally: Only 2 (smallpox in
1979 via $300M WHO effort over <10 years; rinderpest) NIH role:
Contributor to research/vaccine development but not sole eradicator
Near-eradication: Polio (close to achievement); measles, rubella
targeted for eradication Major achievements via vaccination: Smallpox
eradicated, polio nearly eliminated, diphtheria/tetanus/measles greatly
reduced Impact: Vaccination eliminated disease in populations with high
implementation rates; past 2 centuries saw enormous infectious disease
control via sanitation, vaccines, antibiotics, nutrition Additional
sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7612385/ |
https://pmc.ncbi.nlm.nih.gov/articles/PMC4024226/ |
https://www.ncbi.nlm.nih.gov/books/NBK98117/
.145.
HHS. FY2016 budget in brief - NIH. HHS
https://www.hhs.gov/about/budget/budget-in-brief/nih/index.html
(2020)
NIH funding contributed to published
research associated with every one of the 356 new drugs approved by the
FDA from 2010–2019." Total NIH spending on this research was $187
billion, while industry spending on clinical development for these drugs
was significantly higher. Approximately 54% of the NIH research budget
is devoted to basic biomedical and behavioral research, while about
one-third (33%) is allocated to clinical research including
patient-oriented research, clinical trials, and health services
research. Categories overlap so totals exceed 100%. Additional sources:
https://www.pnas.org/doi/10.1073/pnas.1920929117 |
https://marianamazzucato.com/books/the-entrepreneurial-state |
https://www.hhs.gov/about/budget/budget-in-brief/nih/index.html |
https://www.hhs.gov/about/budget/budget-in-brief/nih/index.html
.146.
Journal, S. V. B. NIH funding cuts and brain
drain. Silicon Valley Business Journal https://www.bizjournals.com/sanjose/news/2025/08/15/nih-funding-cuts-science-brain-drain-berkeley.html
(2025)
Following a proposed 29% cut to NIH
funding in 2025, 75% of scientists are considering leaving the U.S. due
to funding instability. Additional sources:
https://www.bizjournals.com/sanjose/news/2025/08/15/nih-funding-cuts-science-brain-drain-berkeley.html
.147.
ScienceDirect. Correlation between NIH funding
priorities and disease burden. ScienceDirect: Persistence of Very
Low Correlations https://www.sciencedirect.com/science/article/pii/S2666535224001174
Very weak correlations: R² < 0.03 between NIH
funding and 5 disease burden measures for 27 diseases Historical (1996):
r=0.62 correlation with DALYs, but explained only 39% of variance Recent
(2008-2019): Simple correlation 0.08 between disease burden increases
and funding increases 2019 analysis: Only 29% of variance in NIH funding
explained by disease burden Strongest predictor of 2019 funding: 2008
funding levels (r=0.88), revealing long-standing inefficiencies
Additional sources:
https://www.sciencedirect.com/science/article/pii/S2666535224001174 |
https://www.nejm.org/doi/full/10.1056/NEJM199906173402406 |
https://pmc.ncbi.nlm.nih.gov/articles/PMC3044706/
.148.
News Reports, R. I. &. NIH RECOVER
initiative inefficiency. RECOVER Initiative & News Reports
https://recovercovid.org/about
(2025).
149.
Wikipedia. The nuclear disarmament "freeze"
movement of the 1980s. Wikipedia: Nuclear Freeze Campaign https://en.wikipedia.org/wiki/Nuclear_Freeze_campaign
(2010)
Mass U.S. movement (1980s) to halt
testing, production, deployment of nuclear weapons between U.S. and
Soviet Union Origins: Proposed by Randall Forsberg (Dec 1979); Nuclear
Weapons Freeze Campaign formed March 1981 at Georgetown University June
12, 1982: 1 million people rallied in NYC (largest peacetime rally in
U.S. history) 1983: Congress passed nuclear freeze resolution Impact:
Reagan administration reversed rhetoric ("nuclear war cannot be won and
must never be fought") Major support: Religious community (National
Council of Churches, Protestant denominations, progressive evangelicals,
African-American churches) 1987: Merged with Committee for a Sane
Nuclear Policy → formed Peace Action Additional sources:
https://en.wikipedia.org/wiki/Nuclear_Freeze_campaign |
https://www.armscontrol.org/act/2010-12/nuclear-freeze-and-its-impact |
https://disarmament.blogs.pace.edu/nyc-nuclear-archive/nuclear-freeze-campaign-1970s-1980s/
.150.
Xia et al., N. F. Nuclear winter famine.
Xia et al. https://www.nature.com/articles/s43016-022-00573-0
(2022)
We estimate that a nuclear war between
the United States and Russia would produce 150 Tg of soot and lead to 5
billion people dying at the end of year 2. Additional sources:
https://www.nature.com/articles/s43016-022-00573-0
.151.
CDC. Obesity epidemic statistics. CDC
https://www.cdc.gov/nchs/products/databriefs/db360.htm
(2020)
The US obesity prevalence was 42.4% in
2017-2018, and the prevalence of severe obesity increased from 4.7% to
9.2%. Additional sources:
https://www.cdc.gov/nchs/products/databriefs/db360.htm
.152.
Wikipedia. Occupy wall street movement (2011).
Wikipedia: Occupy Wall Street https://en.wikipedia.org/wiki/Occupy_Wall_Street
Left-wing populist movement against economic
inequality, capitalism, corporate greed, big finance, money in politics
September 17 - November 15, 2011 (59 days) in Zuccotti Park, NYC
Financial District Slogan "We are the 99%" highlighted income/wealth
inequality: Top 1% owned 40% of wealth, earned 20% of income (2011)
Organized by Adbusters (Kalle Lasn, Micah White); ended November 15 when
police cleared park ( 200 arrested) Legacy: Successfully reframed
national conversation about economic inequality in simple, effective
terms Additional sources:
https://en.wikipedia.org/wiki/Occupy_Wall_Street |
https://www.britannica.com/topic/Occupy-Wall-Street |
https://history.com/this-day-in-history/occupy-wall-street-begins-zuccotti-park
.153.
Columbia/NBER. Odds of a single vote being
decisive in a u.s. Presidential election. Columbia/NBER: What Is the
Probability Your Vote Will Make a Difference? https://sites.stat.columbia.edu/gelman/research/published/probdecisive2.pdf
(2012)
National average: 1 in 60 million
chance (2008 election analysis by Gelman, Silver, Edlin) Swing states
(NM, VA, NH, CO): 1 in 10 million chance Non-competitive states: 34
states >1 in 100 million odds; 20 states >1 in 1 billion
Washington DC: 1 in 490 billion odds Methodology: Probability state is
necessary for electoral college win × probability state vote is tied
Additional sources:
https://sites.stat.columbia.edu/gelman/research/published/probdecisive2.pdf
|
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1465-7295.2010.00272.x
.154.
Research, G. V. Open-source and
platform-as-a-service multi-trillion dollar market. Grand View
Research: Open Source Services Market https://www.grandviewresearch.com/industry-analysis/open-source-services-market-report
Open source services market: $30.2B (2023) →
$81.4B (2030) at 16.5% CAGR; other estimates $135.9B by 2033 Open source
cloud platform: $6.23B (2024) → $18.12B (2033) at 12.8% CAGR Platform as
a Service (PaaS): Growing at 12.6% CAGR Broader cloud computing market:
Projected $1.5 trillion by 2033 at 15% CAGR Current market in tens of
billions, approaching multi-trillion valuations in long term Additional
sources:
https://www.grandviewresearch.com/industry-analysis/open-source-services-market-report
|
https://www.precedenceresearch.com/open-source-services-market
.155.
Data, O. W. in. Pandemic vs. War deaths
comparison. Our World in Data https://ourworldindata.org/covid-deaths
(2024)
COVID-19 deaths: over 7 million
confirmed deaths" vs. annual conflict deaths typically under 100,000.
Additional sources:
https://ourworldindata.org/covid-deaths
.156.
Trials. Patient willingness to participate in
clinical trials. Trials: Patients’ Willingness Survey https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1105-3
Recent surveys: 49-51% willingness (2020-2022) -
dramatic drop from 85% (2019) during COVID-19 pandemic Cancer patients
when approached: 88% consented to trials (Royal Marsden Hospital) Study
type variation: 44.8% willing for drug trial, 76.2% for diagnostic study
Top motivation: "Learning more about my health/medical condition"
(67.4%) Top barrier: "Worry about experiencing side effects" (52.6%)
Additional sources:
https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-1105-3
|
https://www.appliedclinicaltrialsonline.com/view/industry-forced-to-rethink-patient-participation-in-trials
| https://pmc.ncbi.nlm.nih.gov/articles/PMC7183682/
.157.
Wikipedia. Patrick soon-shiong’s focus on
cancer research. Wikipedia: Patrick Soon-Shiong https://en.wikipedia.org/wiki/Patrick_Soon-Shiong
(2017)
Billionaire biotech entrepreneur (net
worth $12B, 2025); founder of NantWorks (healthcare/biotech/AI startups)
Key achievements: Invented Abraxane (FDA-approved for metastatic breast,
lung, advanced pancreatic cancer); first drug in 20+ years showing
significant survival improvement for metastatic pancreatic cancer Recent
breakthrough: Anktiva (new immunotherapy class) FDA-approved April 2024
for non-muscle invasive bladder cancer; 71% complete remission, 24.1
median duration Companies: Executive Chairman of NantKwest
(immunotherapy, natural killer cells); Chairman/CEO of ImmunityBio
(vaccines/immunotherapy for cancer/infectious diseases) 2016 Cancer
Moonshot: Goal to enroll 20,000 patients in trials, develop effective
vaccine by 2020 (faced criticism, fell short of goals) Additional
sources: https://en.wikipedia.org/wiki/Patrick_Soon-Shiong |
https://www.statnews.com/2017/03/27/soon-shiong-cancer-video-questions/
|
https://www.biospace.com/patrick-soon-shiong-s-cancer-moonshot-slow-progress-but-some-news
.158.
Wikipedia. Passage of the USA PATRIOT act.
Wikipedia: Patriot Act https://en.wikipedia.org/wiki/Patriot_Act
(2001)
Introduced: October 23, 2001 by Rep.
Jim Sensenbrenner (R-WI) as H.R. 3162 Passed House: October 24, 2001
(357-66 vote, Democrats majority of "no" votes) Passed Senate: October
25, 2001 (98-1 vote, only Russ Feingold D-WI voted "no") Signed into
law: October 26, 2001 by President George W. Bush Length: 342 pages,
passed hastily without public opportunity for review ACLU concern:
Senate forced to vote on legislation it hadn’t had opportunity to read
(offices closed, staff couldn’t access papers) Additional sources:
https://en.wikipedia.org/wiki/Patriot_Act |
https://www.britannica.com/topic/USA-PATRIOT-Act |
https://www.ala.org/advocacy/chronology-usa-patriot-act-2001
.159.
U.S. Congress. 42 u.s. Code §
1320e-1 - limitations on certain uses of comparative clinical
effectiveness research. (2010)
Exact
statutory text: "The Patient-Centered Outcomes Research Institute
established under section 1320e(b)(1) of this title shall not develop or
employ a dollars-per-quality adjusted life year (or similar measure that
discounts the value of a life because of an individual’s disability) as
a threshold to establish what type of health care is cost effective or
recommended." The Secretary also cannot use such thresholds for Medicare
coverage or reimbursement decisions.
160.
Hester M. Peirce, S. C. Token safe harbor
concept (peirce 2.0). Hester M. Peirce https://www.sec.gov/news/public-statement/peirce-statement-token-safe-harbor-proposal-2.0
(2021)
The safe harbor seeks to provide
network developers with a three‑year grace period... to facilitate
participation in, and the development of, a functional or decentralized
network. Additional sources:
https://www.sec.gov/news/public-statement/peirce-statement-token-safe-harbor-proposal-2.0
.161.
Commune, T. Pentagon audit failures ($2.46T
unaccounted). The Commune https://thecommunemag.com/the-pentagon-misplaced-2-46-trillion-an-in-depth-look-at-the-financial-audit-failures
(2024)
In the most recent audit, the
Department of Defense (DoD) could not account for approximately 60% of
its 4.1trillioninassets, amountingto2.46
trillion unaccounted for. Alternative title: Pentagon unsupported
accounting adjustments (6.5T, singleyear, USArmy)In2015, theDepartmentofDefense′sInspectorGeneralreportedthattheArmycouldnotadequatelysupport6.5
trillion in year-end adjustments, indicating severe accounting
discrepancies. Additional sources:
https://thecommunemag.com/the-pentagon-misplaced-2-46-trillion-an-in-depth-look-at-the-financial-audit-failures
|
https://accmag.com/audit-pentagon-cannot-account-for-6-5-trillion-dollars-is-taxpayer-money/
.162.
OpenSecrets. Pharmaceutical industry lobbying
statistics. OpenSecrets: Pharmaceuticals/Health Products https://www.opensecrets.org/industries/indus?ind=H04
Pharmaceutical and health products industry spent
$388 million on federal lobbying in 2024 ($6.1 billion since 1999)
Employs roughly 3 lobbyists for every member of Congress Note: The
industry has consistently been among the top spenders on lobbying in
Washington D.C., with major pharmaceutical companies like Pfizer,
AbbVie, and PhRMA leading expenditures Additional sources:
https://www.opensecrets.org/industries/indus?ind=H04
.163.
PMC. Pharmaceutical industry annual profits.
PMC: Profitability of Large Pharmaceutical Companies https://pmc.ncbi.nlm.nih.gov/articles/PMC7054843/
Net income (2000-2018): 35 large pharma companies
earned $1.9T cumulative net income on $11.5T revenue 2022 profits: Major
pharma companies made >$112B in profits Profit margins: Pharma
companies 13.8% median vs 7.7% for other S&P 500 companies Largest
25 companies: 15-20% annual average profit margin vs 4-9% for non-drug
companies globally Profitability: Pharma significantly more profitable
than most S&P 500 companies Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC7054843/ |
https://www.bentley.edu/news/new-research-shows-pharma-companies-are-more-profitable-most-sp-500-companies
| https://www.gao.gov/products/gao-18-40
.164.
PMC. Pragmatic trial cost per patient (median
$97). PMC: Costs of Pragmatic Clinical Trials https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/
The median cost per participant was $97 (IQR
$19–$478), based on 2015 dollars. Systematic review of 64 embedded
pragmatic clinical trials. 25% of trials cost <$19/patient; 10 trials
exceeded $1,000/patient. U.S. studies median $187 vs non-U.S. median
$27. Additional sources:
https://pmc.ncbi.nlm.nih.gov/articles/PMC6508852/
.165.
One, P. Polypill for primary prevention cost
per QALY. PLOS One https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182625
A polypill strategy was potentially
cost-effective compared to other strategies for most sub-groups ranging
from dominance to up to £18,811 per QALY depending on patient sub-group.
Additional sources:
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0182625
.166.
Foundation, E. Proof-of-stake energy
efficiency. Ethereum Foundation: ETH Will Use 99.95 https://blog.ethereum.org/2021/05/18/country-power-no-more
(2021)
Ethereum’s "Merge" (Sept 15, 2022):
Transition from proof-of-work to proof-of-stake Energy reduction:
99.9-99.95% less energy consumption ( 2000X more energy-efficient)
Actual consumption drop: 23M megawatt hours/year → 2,600 megawatt
hours/year Carbon footprint: 99.992% reduction (11.016M tonnes CO2e →
870 tonnes CO2e) Additional sources:
https://blog.ethereum.org/2021/05/18/country-power-no-more |
https://ethereum.org/energy-consumption/ |
https://decrypt.co/109848/ethereum-energy-carbon-footprint-down-99-percent-merge
.167.
Kinch, M. S. & Griesenauer, R. H. Lost medicines: A
longer view of the pharmaceutical industry with the potential to
reinvigorate discovery. Drug Discovery Today
24, 875–880 (2019)
Research
identified 1,600+ medicines available in 1962. The 1950s represented
industry high-water mark with >30 new products in five of ten years;
this rate would not be replicated until late 1990s. More than half (880)
of these medicines were lost following implementation of Kefauver-Harris
Amendment. The peak of 1962 would not be seen again until early 21st
century. By 2016 number of organizations actively involved in R&D at
level not seen since 1914.
168.
Study of Drug Development, T. C. for. Post-1962
explosion in drug development costs. Tufts Center for Study of Drug
Development https://csdd.tufts.edu/cost-study
(2014)
Cost to develop a new prescription
drug: $2.6 billion (2014 Tufts study), increasing to $2.9 billion with
post-approval development Represents 145% increase (inflation-adjusted)
from 2003 estimate of $802 million Based on 106 drugs from 10
pharmaceutical companies tested between 1995-2007 Note: This study has
been controversial; some organizations like Doctors Without Borders
suggest actual costs may be substantially lower. Deloitte 2023 report
shows costs continuing to rise Additional sources:
https://csdd.tufts.edu/cost-study |
https://cen.acs.org/articles/92/web/2014/11/Tufts-Study-Finds-Big-Rise.html
.169.
CSV, S. U. L. E. F. B. 1543-2019. Post-1962
slowdown in life expectancy gains. (2019)
Pre-1962 (1880-1960): 3.82 years/decade Post-1962 (1962-2019): 1.54
years/decade Reduction: 60% decline Temporal correlation: Slowdown
occurred immediately after 1962 Kefauver-Harris Amendment See detailed
calculation:
[life-expectancy-increase-pre-1962](#life-expectancy-increase-pre-1962)
Additional sources: https://ourworldindata.org/life-expectancy |
https://www.mortality.org/ |
https://www.cdc.gov/nchs/nvss/mortality_tables.htm
.170.
Fund, N. C. NIH pragmatic trials: Minimal
funding despite 30x cost advantage. NIH Common Fund: HCS Research
Collaboratory https://commonfund.nih.gov/hcscollaboratory
(2025)
The NIH Pragmatic Trials Collaboratory
funds trials at **$500K for planning phase, $1M/year for
implementation**—a tiny fraction of NIH’s budget. The ADAPTABLE trial
cost **$14 million** for **15,076 patients** (= **$929/patient**) versus
**$420 million** for a similar traditional RCT (30x cheaper), yet
pragmatic trials remain severely underfunded. PCORnet infrastructure
enables real-world trials embedded in healthcare systems, but receives
minimal support compared to basic research funding. Additional sources:
https://commonfund.nih.gov/hcscollaboratory |
https://pcornet.org/wp-content/uploads/2025/08/ADAPTABLE_Lay_Summary_21JUL2025.pdf
|
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604499/
.171.
Pre-1962 Drug Development Costs
(Congressional Testimony, Alternative Estimate). https://www.congress.gov/95/crecb/1977/04/21/GPO-CRECB-1977-pt10-2-3.pdf
(1977)
1962: Average cost $1.2 million (in
1962 dollars) 1972: $11.5 million 1977: Projected $40 million
Inflation-adjusted to 2024 dollars: $1.2M (1962) ≈ $12M (2024), using
CPI multiplier of 10× Real cost increase (inflation-adjusted): $12M
(1962) → $2,600M (2024) = 217× increase Note: Lower estimate than Baily
(1972); may reflect incomplete cost accounting or different drug types.
Baily’s $6.5M (1980 dollars) = $22.5M (2024 dollars) is the more
rigorous academic estimate Additional sources:
https://www.congress.gov/95/crecb/1977/04/21/GPO-CRECB-1977-pt10-2-3.pdf
.172.
Numbers, T. by. Pre-1962 drug development costs
and timeline (think by numbers). Think by Numbers: How Many Lives
Does FDA Save? https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/
(1962)
Historical estimates (1970-1985): USD
$226M fully capitalized (2011 prices) 1980s drugs: $65M after-tax
R&D (1990 dollars), $194M compounded to approval (1990 dollars)
Modern comparison: $2-3B costs, 7-12 years (dramatic increase from
pre-1962) Context: 1962 regulatory clampdown reduced new treatment
production by 70%, dramatically increasing development timelines and
costs Note: Secondary source; less reliable than Congressional testimony
Additional sources:
https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/
| https://en.wikipedia.org/wiki/Cost_of_drug_development |
https://www.statnews.com/2018/10/01/changing-1962-law-slash-drug-prices/
.173.
Numbers, T. by. Pre-1962 physician-led clinical
trials. Think by Numbers: How Many Lives Does FDA Save? https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/
(1966)
Pre-1962: Physicians could report
real-world evidence directly 1962 Drug Amendments replaced "premarket
notification" with "premarket approval", requiring extensive efficacy
testing Impact: New regulatory clampdown reduced new treatment
production by 70%; lifespan growth declined from 4 years/decade to 2
years/decade Drug Efficacy Study Implementation (DESI): NAS/NRC
evaluated 3,400+ drugs approved 1938-1962 for safety only; reviewed
>3,000 products, >16,000 therapeutic claims FDA has had authority
to accept real-world evidence since 1962, clarified by 21st Century
Cures Act (2016) Note: Specific "144,000 physicians" figure not verified
in sources Additional sources:
https://thinkbynumbers.org/health/how-many-net-lives-does-the-fda-save/
|
https://www.fda.gov/drugs/enforcement-activities-fda/drug-efficacy-study-implementation-desi
|
http://www.nasonline.org/about-nas/history/archives/collections/des-1966-1969-1.html
.174.
arXiv. Preferential target attachment in
clinical trials. arXiv https://arxiv.org/abs/2301.10709
(2023)
Clinical trials overwhelmingly test
the same few biological targets due to preferential attachment dynamics.
Additional sources: https://arxiv.org/abs/2301.10709
.175.
Bowles, S. Prehistoric violence rates.
Bowles https://www.science.org/doi/10.1126/science.1168112
(2009)
Archaeological evidence suggests that
approximately 15% of prehistoric humans died from violence, compared to
less than 1% in modern developed nations. Additional sources:
https://www.science.org/doi/10.1126/science.1168112
.176.
Princeton. Princeton study on policy outcomes
and influence of elites vs. Average citizens. Princeton: Testing
Theories of American Politics (PDF) https://archive.org/details/gilens_and_page_2014_-testing_theories_of_american_politics.doc
(2014)
Study by Martin Gilens (Princeton) and
Benjamin I. Page (Northwestern): Analyzed 1,779 policy outcomes
(1981-2002) Finding: "Economic elites and organized groups representing
business interests have substantial independent impacts on U.S.
government policy, while average citizens have little or no independent
influence Rich, well-connected individuals steer the country’s
direction, regardless of or even against the will of the majority of
voters Note: Specific "78 percent" and "zero percent correlation"
statistics not found in sources Additional sources:
https://scholar.princeton.edu/sites/default/files/mgilens/files/gilens_and_page_2014_-testing_theories_of_american_politics.doc.pdf
| https://act.represent.us/sign/usa-oligarchy-research-explained |
https://archive.org/details/gilens_and_page_2014_-testing_theories_of_american_politics.doc
.177.
PubMed. Psychological impact of war cost ($100B
annually). PubMed: Economic Burden of PTSD https://pubmed.ncbi.nlm.nih.gov/35485933/
PTSD economic burden (2018 U.S.): $232.2B total
($189.5B civilian, $42.7B military) Civilian costs driven by: Direct
healthcare ($66B), unemployment ($42.7B) Military costs driven by:
Disability ($17.8B), direct healthcare ($10.1B) Exceeds costs of other
mental health conditions (anxiety, depression) War-exposed populations:
2-3X higher rates of anxiety, depression, PTSD; women and children most
vulnerable Note: Actual burden $232B, significantly higher than "$100B"
claimed Additional sources: https://pubmed.ncbi.nlm.nih.gov/35485933/ |
https://news.va.gov/103611/study-national-economic-burden-of-ptsd-staggering/
| https://pmc.ncbi.nlm.nih.gov/articles/PMC9957523/
.178.
AllTrials. Publication rate of clinical trial
results. AllTrials: Half of Trials Unreported https://www.alltrials.net/news/half-of-all-trials-unreported/
(2013)
50.0% of clinical trials never
publish results (NHS-funded systematic review, 2010) Schmucker et al
(2014): 53% of trials published (analyzing 39 studies, >20,000
trials) Munch et al (2014): 46% of pain treatment trials published Chang
et al (2015): 49% of high-risk cardiac device trials published Positive
findings: 3X more likely to be published than negative results
Antidepressant example: Published literature showed 94% positive trials;
FDA analysis showed only 51% positive Additional sources:
https://www.alltrials.net/news/half-of-all-trials-unreported/ |
https://www.nature.com/articles/nature.2013.14286 |
https://pmc.ncbi.nlm.nih.gov/articles/PMC8276556/
.179.
IMF. Reconstruction costs from active
conflicts. IMF: Cost of Conflict https://www.imf.org/external/pubs/ft/fandd/2017/12/imus.htm
(2017)
Individual conflict examples: Libya,
Syria, Yemen $300B combined (World Bank) Syria alone: $250B-$1T
estimates Ukraine: >€500B reconstruction costs Gaza: $18.5B
infrastructure damage Global conflict/violence cost: $14.3T/year (2016,
includes military spending, security, losses) Note: Specific "$1,875B
for 47 conflicts" figure not verified in sources Additional sources:
https://www.imf.org/external/pubs/ft/fandd/2017/12/imus.htm |
https://www.weforum.org/stories/2018/01/conflict-costs-global-economy-14-trillion-a-year/
|
https://fortune.com/2022/04/21/ukraine-reconstruction-cost-rebuild-economists-plan-russia-foot-trillion-bill/
.180.
Initiative, R. RECOVER initiative budget update
(>$2.3B). RECOVER Initiative https://recovercovid.org/news/nih-adds-funds-long-covid-research-advances-work-new-clinical-trials
(2024).
181.
NIH. NIH RECOVER initiative patient enrollment
numbers. NIH: RECOVER Initiative Enrollment https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19
Enrolled: 30,000 people in ongoing studies and
clinical trials Goal: 40,000 adults and children $1.15B effort
(including American Rescue Plan Act 2021 support) One of largest, most
diverse Long COVID cohorts in world Additional sources:
https://www.nih.gov/news-events/news-releases/nih-builds-large-nationwide-study-population-tens-thousands-support-research-long-term-effects-covid-19
|
https://recovercovid.org/news/nih-launches-long-covid-clinical-trials-through-recover-initiative-opening-enrollment
.182.
Oren Cass, M. I. RECOVERY trial cost per
patient. Oren Cass https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs
(2023)
The RECOVERY trial, for example, cost
only about 500perpatient...Bycontrast, themedianper − patientcostofapivotaltrialforanewtherapeuticisaround41,000.
Additional sources:
https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs
.183.
Oxford, U. of. RECOVERY trial time to first
cure. University of Oxford https://www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalised-patients-severe-respiratory-complications
(2020)
100 days to first cure Additional
sources:
https://www.ox.ac.uk/news/2020-06-16-dexamethasone-reduces-death-hospitalised-patients-severe-respiratory-complications
|
https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19
.184.
al., N. E. Á. et. RECOVERY trial global lives
saved ( 1 million). NHS England: 1 Million Lives Saved https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/
(2021)
Dexamethasone saved 1 million lives
worldwide (NHS England estimate, March 2021, 9 months after discovery).
UK alone: 22,000 lives saved. Methodology: Águas et al. Nature
Communications 2021 estimated 650,000 lives (range: 240,000-1,400,000)
for July-December 2020 alone, based on RECOVERY trial mortality
reductions (36% for ventilated, 18% for oxygen-only patients) applied to
global COVID hospitalizations. June 2020 announcement: Dexamethasone
reduced deaths by up to 1/3 (ventilated patients), 1/5 (oxygen
patients). Impact immediate: Adopted into standard care globally within
hours of announcement. Additional sources:
https://www.england.nhs.uk/2021/03/covid-treatment-developed-in-the-nhs-saves-a-million-lives/
| https://www.nature.com/articles/s41467-021-21134-2 |
https://pharmaceutical-journal.com/article/news/steroid-has-saved-the-lives-of-one-million-covid-19-patients-worldwide-figures-show
|
https://www.recoverytrial.net/news/recovery-trial-celebrates-two-year-anniversary-of-life-saving-dexamethasone-result
.185.
Institute, M. RECOVERY trial 82× cost
reduction. Manhattan Institute: Slow Costly Trials https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs
RECOVERY trial: $500 per patient ($20M for
48,000 patients = $417/patient) Typical clinical trial: $41,000 median
per-patient cost Cost reduction: 80-82× cheaper ($41,000 ÷ $500 ≈ 82×)
Efficiency: $50 per patient per answer (10 therapeutics tested, 4
effective) Dexamethasone estimated to save >630,000 lives Additional
sources:
https://manhattan.institute/article/slow-costly-clinical-trials-drag-down-biomedical-breakthroughs
| https://pmc.ncbi.nlm.nih.gov/articles/PMC9293394/
.186.
Trial, R. RECOVERY trial cost reduction.
RECOVERY Trial https://www.recoverytrial.net/
Oxford RECOVERY trial achieved $500 per patient
cost, compared to traditional Phase III trial costs of $40,000-120,000+
per patient. This represents an 80-100x+ cost reduction. Key strategies:
embedding trial protocols within routine hospital care, minimizing
overhead by leveraging existing staff/resources and electronic data
capture, and focused pragmatic trial designs. Additional sources:
https://www.recoverytrial.net/
.187.
Trial, R. RECOVERY trial dexamethasone results.
RECOVERY Trial https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19
Dexamethasone reduced deaths by one-third in
ventilated patients (rate ratio 0.65 [95% confidence interval 0.48 to
0.88]; $p=0.0003$) and by one fifth in other patients receiving oxygen
only (0.80 [0.67 to 0.96]; $p=0.0021$) Additional sources:
https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-by-up-to-one-third-in-hospitalised-patients-with-severe-respiratory-complications-of-covid-19
.188.
News, O. U. RECOVERY trial summary quote.
Oxford University News https://www.ox.ac.uk/news/features/recovery-trial-two-years
One trial. Over 47,000 participants. Nearly 200
hospital sites, across six countries. Ten results. Four effective
COVID-19 treatments... Through discovering four treatments that
effectively reduce deaths from COVID-19, it is certain that the study
has saved thousands – if not millions – of lives worldwide. Additional
sources:
https://www.ox.ac.uk/news/features/recovery-trial-two-years
.189.
ASPE. Refugee lost annual earning potential
($23,400). ASPE: Fiscal Impact of Refugees https://aspe.hhs.gov/reports/fiscal-impact-refugees-asylees
Refugee economic impact: Net positive $123.8B
fiscal impact (2005-2019, 15 years) Refugees pay $21K more in taxes than
benefits received over first 20 years in U.S. Earnings gap: Refugees
work at higher rates than natives but earn less; never reach U.S.-born
earning levels Income progression: <5 years in U.S. = $30,500 median;
20+ years = $71,400 (exceeds national $67,100 median) Note: Specific
"$23,400 lost earning potential" figure not verified in sources
Additional sources:
https://aspe.hhs.gov/reports/fiscal-impact-refugees-asylees |
https://www.americanimmigrationcouncil.org/sites/default/files/research/05.23_refugee_report_v3_0.pdf
|
https://www.nber.org/system/files/working_papers/w23498/w23498.pdf
.190.
Forest, W. Milestones in regenerative medicine
and tissue engineering. Wake Forest: Record of Firsts https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/research/a-record-of-firsts
1999: First 3D-printed organ (bladder)
transplanted into human (Wake Forest Institute, still functioning 20+
years later) Windpipes (trachea): 3D-printed windpipe transplants
performed; patient received biodegradable 5-year windpipe Blood vessels,
skin: Mobile bioprinters can print skin directly onto wounds at patient
bedside Tubular organs: Urine conduits engineered and implanted in
patients 3D-printed ear implant: World’s first successfully transplanted
Current status: Can print flat structures (skin), tubular (blood
vessels), hollow non-tubular (bladder); complex life-sized organs 20-30
years away Additional sources:
https://school.wakehealth.edu/research/institutes-and-centers/wake-forest-institute-for-regenerative-medicine/research/a-record-of-firsts
| https://builtin.com/articles/3d-printed-organs |
https://pmc.ncbi.nlm.nih.gov/articles/PMC5313259/
.191.
JAMA. Research to practice gap (17 years).
JAMA https://pubmed.ncbi.nlm.nih.gov/37018006/
(2023)
It takes an average of 17 years for
new scientific evidence to be implemented into clinical practice.
Additional sources:
https://pubmed.ncbi.nlm.nih.gov/37018006/
.192.
WHO. Annual deaths from respiratory disease.
WHO: COPD Fact Sheet) https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd
(2019)
Chronic respiratory diseases: 4.0
million deaths annually (2019) COPD specifically: 3.5 million deaths
(2021) - 4th leading cause of death globally Pneumonia: 2.5 million
deaths including 672,000 children (2019) Combined respiratory deaths:
6.5 million annually Note: 90% of COPD deaths in those under 70 occur
in low- and middle-income countries. COPD affects over 380 million
people globally Additional sources:
https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd
|
https://www.healthdata.org/research-analysis/library/global-burden-chronic-respiratory-diseases-and-risk-factors-1990-2019
.193.
Congress.gov. Right to try act (2018).
Congress.gov https://www.congress.gov/bill/115th-congress/house-bill/2368
(2018)
Right to Try Act (2018) Additional
sources: https://www.congress.gov/bill/115th-congress/house-bill/2368 |
https://pmc.ncbi.nlm.nih.gov/articles/PMC7416898/
.194.
PMC. Number of patients helped by the u.s.
Right to try act. PMC: Understanding Right to Try https://pmc.ncbi.nlm.nih.gov/articles/PMC7416898/
(2024)
2018-2022: Supported access to only 12
products total; 4 products in 2023 Number of people treated: Not
publicly reported, "likely only in the hundreds Specific documented
cases: 75+ neuroendocrine cancer patients (LU-177); at least 1 ALS
patient (NurOwn); 7 glioblastoma patients (Gliovac) Minimal safety
reporting: Only annual basis, no requirement to publish results/outcomes
Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC7416898/ |
https://www.statnews.com/2024/08/02/trump-gave-patients-right-to-try-it-hasnt-helped-them/
|
https://www.healio.com/news/hematology-oncology/20200303/right-to-try-a-wellintentioned-but-misguided-law
.196.
Dawkins, R. The selfish gene quote. Richard
Dawkins https://en.wikipedia.org/wiki/The_Selfish_Gene
(1976)
We are survival machines, robot
vehicles blindly programmed to preserve the selfish molecules known as
genes. Additional sources:
https://en.wikipedia.org/wiki/The_Selfish_Gene
.197.
Institute, S. I. P. R. Trends
in world military expenditure, 2023. (2024).
198.
WHO. Smallpox eradicated. WHO https://www.who.int/health-topics/smallpox
Following a successful global eradication
campaign, the World Health Assembly officially declared the world free
of smallpox in 1980. Additional sources:
https://www.who.int/health-topics/smallpox
.199.
CSIS. Smallpox eradication ROI. CSIS
https://www.csis.org/analysis/smallpox-eradication-model-global-cooperation.
200.
Finance, Y. George soros’s 1992 bet against the
british pound. Yahoo Finance: British Pounding https://finance.yahoo.com/news/british-pounding-george-soros-made-160033593.html
Black Wednesday (September 16, 1992): Soros
assembled $10 billion short position against British pound Increased
position from $1.5B to $10B that morning; bought German marks while
selling pounds Profit: Over £1 billion ($1-1.5 billion) in single day UK
Treasury cost: £3.3 billion; Bank of England spent $29 billion trying to
defend pound Pound fell 15% vs. German mark, 25% vs. dollar; UK forced
to exit European Exchange Rate Mechanism Earned Soros title "the man who
broke the Bank of England Additional sources:
https://finance.yahoo.com/news/british-pounding-george-soros-made-160033593.html
| https://en.wikipedia.org/wiki/Black_Wednesday |
https://www.thebalancemoney.com/black-wednesday-george-soros-bet-against-britain-1978944
.201.
UK, H. The south sea bubble of 1720.
Historic UK: South Sea Bubble https://www.historic-uk.com/HistoryUK/HistoryofEngland/South-Sea-Bubble/
South Sea Company founded 1711 as public-private
partnership to consolidate national debt Granted monopoly (Asiento de
Negros) to supply African slaves to South America (1713) Stock price
explosion: £128 (Jan 1720) → £175 (Feb) → £330 (Mar) → £550 (May) →
£1,000 (Aug) Reality: No realistic prospect of trade; Company never
realized significant profit from monopoly Collapse: By September market
crashed; December shares down to £124 Called world’s first financial
crash, first Ponzi scheme, classic "group think" speculation mania Story
disconnected from actual (negligible) profits Additional sources:
https://www.historic-uk.com/HistoryUK/HistoryofEngland/South-Sea-Bubble/
| https://en.wikipedia.org/wiki/South_Sea_Company |
https://www.britannica.com/money/South-Sea-Bubble
.202.
PMC. Standard medical research ROI
($20k-$100k/QALY). PMC: Cost-effectiveness Thresholds Used by Study
Authors https://pmc.ncbi.nlm.nih.gov/articles/PMC10114019/
(1990)
Typical cost-effectiveness thresholds
for medical interventions in rich countries range from $50,000 to
$150,000 per QALY. The Institute for Clinical and Economic Review (ICER)
uses a $100,000-$150,000/QALY threshold for value-based pricing. Between
1990-2021, authors increasingly cited $100,000 (47% by 2020-21) or
$150,000 (24% by 2020-21) per QALY as benchmarks for cost-effectiveness.
Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10114019/ |
https://icer.org/our-approach/methods-process/cost-effectiveness-the-qaly-and-the-evlyg/
.203.
Lancet, T. Statins for high-risk patients cost
per QALY. The Lancet https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24
Standard statin was cost-effective across all
categories with incremental cost per QALY from £280 to £8530, with
higher intensity statin cost-effective at higher cardiovascular risks
and higher LDL-C levels. Additional sources:
https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24
.204.
GAO. Annual cost of u.s. Sugar subsidies.
GAO: Sugar Program https://www.gao.gov/products/gao-24-106144
Consumer costs: $2.5-3.5 billion per year (GAO
estimate) Net economic cost: $1 billion per year 2022: US consumers
paid 2X world price for sugar Program costs $3-4 billion/year but no
federal budget impact (costs passed directly to consumers via higher
prices) Employment impact: 10,000-20,000 manufacturing jobs lost
annually in sugar-reliant industries (confectionery, etc.) Multiple
studies confirm: Sweetener Users Association ($2.9-3.5B), AEI ($2.4B
consumer cost), Beghin & Elobeid ($2.9-3.5B consumer surplus)
Additional sources: https://www.gao.gov/products/gao-24-106144 |
https://www.heritage.org/agriculture/report/the-us-sugar-program-bad-consumers-bad-agriculture-and-bad-america
|
https://www.aei.org/articles/the-u-s-spends-4-billion-a-year-subsidizing-stalinist-style-domestic-sugar-production/
.205.
WHO. Global suicide deaths vs. Combat deaths.
WHO https://www.who.int/publications/i/item/9789240110069
(2021)
Suicide deaths: 727,000 annually
(2021), over 700,000 per year on average One person dies by suicide
every 40 seconds 3rd leading cause of death among 15-29 year olds
globally 73% of suicides occur in low- and middle-income countries
Combat deaths: 89,000 annually (significantly lower than suicide) Note:
Link between suicide and mental disorders (depression, alcohol use) is
well-established. With timely, evidence-based interventions, suicides
can be prevented Additional sources:
https://www.who.int/publications/i/item/9789240110069 |
https://www.who.int/news-room/fact-sheets/detail/suicide
.206.
Bank, W. Swiss military budget as percentage of
GDP. World Bank: Military Expenditure https://data.worldbank.org/indicator/MS.MIL.XPND.GD.ZS?locations=CH
2023: 0.70272% of GDP (World Bank) 2024: CHF 5.95
billion official military spending When including militia system costs:
1% GDP (CHF 8.75B) Comparison: Near bottom in Europe; only Ireland,
Malta, Moldova spend less (excluding microstates with no armies)
Additional sources:
https://data.worldbank.org/indicator/MS.MIL.XPND.GD.ZS?locations=CH |
https://www.avenir-suisse.ch/en/blog-defence-spending-switzerland-is-in-better-shape-than-it-seems/
|
https://tradingeconomics.com/switzerland/military-expenditure-percent-of-gdp-wb-data.html
.207.
Bank, W. Switzerland vs. US GDP per capita
comparison. World Bank: Switzerland GDP Per Capita https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=CH
2024 GDP per capita (PPP-adjusted): Switzerland
$93,819 vs United States $75,492 Switzerland’s GDP per capita 24% higher
than US when adjusted for purchasing power parity Nominal 2024:
Switzerland $103,670 vs US $85,810 Additional sources:
https://data.worldbank.org/indicator/NY.GDP.PCAP.CD?locations=CH |
https://tradingeconomics.com/switzerland/gdp-per-capita-ppp |
https://www.theglobaleconomy.com/USA/gdp_per_capita_ppp/
.208.
Tracker, K. H. S. Switzerland vs. US life
expectancy comparison. KFF Health System Tracker: Life Expectancy
Comparison https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
Switzerland: 84 years | United States: 78.4 years
(2023) U.S. has lowest life expectancy among comparable developed
countries (average: 82.5 years) Gap driven by preventable causes:
cardiovascular disease, drug overdoses, firearm violence, motor vehicle
crashes Note: U.S. spends nearly twice as much on healthcare per person
as comparable countries despite lower life expectancy. The disadvantage
began in 1950s and has worsened over past 4 decades Additional sources:
https://www.healthsystemtracker.org/chart-collection/u-s-life-expectancy-compare-countries/
.209.
Wikipedia. Switzerland’s last military
conflict. Wikipedia: Sonderbund War https://en.wikipedia.org/wiki/Sonderbund_War
(2019)
Sonderbund War (November 3-29, 1847):
Last armed conflict on Swiss soil Civil war between 7 Catholic cantons
vs. federal government over centralization Duration: 26 days;
Casualties: 93 deaths total (60 federal, 33 Sonderbund), 510 wounded
Federal army (100,000) led by General Guillaume Henri Dufour defeated
Sonderbund forces Resulted in emergence of Switzerland as federal state;
entered period of peace lasting to present Battle of Gisikon: Last
battle Swiss ever fought Additional sources:
https://en.wikipedia.org/wiki/Sonderbund_War |
https://militaryhistorynow.com/2019/02/27/charm-offensive-switzerlands-polite-war-of-1847/
|
https://www.zeit-fragen.ch/en/archives/2018/no-1-10-january-2018/the-sonderbund-war-the-last-armed-conflict-on-swiss-soil
.210.
Treasury. Troubled asset relief program (TARP)
of 2008. Treasury: TARP About https://home.treasury.gov/data/troubled-assets-relief-program/about-tarp
Authorized: $700 billion (later reduced to $475
billion by Dodd-Frank) Actual disbursed: $443.5 billion to stabilize
financial institutions Bank rescue: $236 billion to 707 financial
institutions in 48 states Breakdown: $250B banking, $82B auto industry,
$70B AIG, $46B foreclosure programs Net lifetime cost: $31.1 billion
(after repayments, sales, dividends, interest); most attributable to
foreclosure programs Passed October 3, 2008 (signed by President Bush);
Emergency Economic Stabilization Act Additional sources:
https://home.treasury.gov/data/troubled-assets-relief-program/about-tarp
| https://en.wikipedia.org/wiki/Troubled_Asset_Relief_Program |
https://www.propublica.org/article/the-bailout-was-11-years-ago-were-still-tracking-every-penny
.211.
FDA. Thalidomide caused thousands of birth
defects. FDA https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy
it resulted in thousands of horrific congenital
disabilities. Additional sources:
https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy
|
https://www.smithsonianmag.com/science-nature/woman-who-stood-between-america-and-epidemic-birth-defects-180963165/
.212.
FDA. FDA dr. Kelsey prevented widespread
thalidomide birth defects in the US. FDA: Frances Oldham Kelsey
https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy
Dr. Frances Kelsey (FDA reviewer) resisted
pressure to approve thalidomide September 1960-November 1961 Worldwide:
8,000 infants born with missing/malformed limbs; 5,000-7,000 perished
in utero United States: 17 confirmed phocomelia cases + 9 likely cases
(vs. 8,000 worldwide) Kelsey insisted on hard evidence, refused to be
browbeaten; repeatedly requested more information every 60 days Merrell
complained to her bosses, calling her "petty bureaucrat" - she persisted
Recognition: President’s Award for Distinguished Federal Civilian
Service (JFK, 1962) Led to 1962 Kefauver-Harris Amendments requiring
drugs prove both safety AND effectiveness Additional sources:
https://www.fda.gov/about-fda/fda-history-exhibits/frances-oldham-kelsey-medical-reviewer-famous-averting-public-health-tragedy
|
https://www.uchicagomedicine.org/forefront/biological-sciences-articles/courageous-physician-scientist-saved-the-us-from-a-birth-defects-catastrophe
|
https://www.smithsonianmag.com/science-nature/woman-who-stood-between-america-and-epidemic-birth-defects-180963165/
.213.
UNDP. Tobacco control ROI. UNDP https://www.undp.org/asia-pacific/blog/how-raising-tobacco-taxes-can-save-lives-and-cut-poverty-across-asia-pacific-0
In our study of six Asia-Pacific countries, we
found that for every unit of local currency invested in increasing
tobacco taxes, the countries would gain between 20 and 1,057 units in
return over 15 years. That’s a remarkable return on investment ratio of
between 20:1 and 1,057:1. Additional sources:
https://www.undp.org/asia-pacific/blog/how-raising-tobacco-taxes-can-save-lives-and-cut-poverty-across-asia-pacific-0
.214.
Investor, A. Top performing private equity
& hedge funds. Alternatives Investor https://alternativesinvestor.com/top-performing-private-equity-funds-2016-2019
(2021)
Top-performing private equity funds,
such as Spectrum’s VIII-A Program, have achieved net IRRs as high as
98.91% for a single vintage year (2017). Renaissance Technologies’
Medallion Fund is famed for achieving an average annualized gross return
of 66%, and a net return of 39%, from 1988 to 2021. Additional
sources:
https://alternativesinvestor.com/top-performing-private-equity-funds-2016-2019
| https://www.traderslog.com/top-hedge-funds
.215.
SIPRI, C. breakdown calculated using. Total
military and war costs: $11.4 trillion.
Direct costs: $7,655B (Military $2.7T + Human casualties $2,446B +
Infrastructure $1,875B + Trade disruption $616B) Indirect costs: $3,700B
(Refugees $1,680B + Diplomatic $800B + Environmental $420B + Opportunity
costs $320B + PTSD $232B + Lost human capital $300B) Total: $11,355.1
billion annually Per capita: $1,419/year; $113,500 over 80-year lifetime
Updated from previous $9.9T estimate due to corrected combat deaths (89K
→ 233,600 per 2024 ACLED data)
.216.
Moore, Z., T. J. & Drug Administration,
2015.-2017. _JAMA. I. Medicine_. Traditional trial cost per patient.
Moore https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295430/
(2020)
The median cost of a pivotal trial was
estimated to be 19million...themediancostperpatientwas41,413.
Additional sources:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295430/
.217.
NCBI, F. S. via. Trial costs, FDA study.
FDA Study via NCBI https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248200/
Overall, the 138 clinical trials had an estimated
median (IQR) cost of 19.0million(12.2
million-33.1million)...Theclinicaltrialscostamedian(IQR)of41,117
(31, 802−82,362) per patient.
Additional sources:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248200/
.218.
WHO. Annual deaths from tuberculosis.
WHO https://www.who.int/news-room/fact-sheets/detail/tuberculosis
(2024)
Tuberculosis | 1.3 million Additional
sources: https://www.who.int/news-room/fact-sheets/detail/tuberculosis |
https://www.who.int/teams/global-programme-on-tuberculosis-and-lung-health/tb-reports/global-tuberculosis-report-2024
.219.
Study of Drug Development, T. C. for the. Tufts
center drug development cost estimate 2021. (2021)
Total cost to develop a new drug estimated at
$2.6 billion as of 2021, nearly a 3-fold increase from $802 million in
2003 (inflation-adjusted).
220.
UNESCO. UNESCO cost for universal education
coverage. UNESCO https://news.un.org/en/story/2023/04/1135697
(2023)
The largest financing gap is in
sub-Saharan Africa: $70 billion per year. An additional $77 billion is
needed annually for African countries to reach their national education
targets and provide quality education for all. Additional sources:
https://news.un.org/en/story/2023/04/1135697 |
https://unesdoc.unesco.org/ark:/48223/pf0000192186
.221.
UNHCR. UNHCR forcibly displaced people 2023.
UNHCR https://www.unhcr.org/global-trends-report-2023
(2023)
At the end of 2023, 117.3 million
people worldwide were forcibly displaced. Additional sources:
https://www.unhcr.org/global-trends-report-2023
.222.
CGDev. UNHCR average refugee support cost.
CGDev https://www.cgdev.org/blog/costs-hosting-refugees-oecd-countries-and-why-uk-outlier
(2024)
The average cost of supporting a
refugee is $1,384 per year. This represents total host country costs
(housing, healthcare, education, security). OECD countries average
$6,100 per refugee (mean 2022-2023), with developing countries spending
$700-1,000. Global weighted average of $1,384 is reasonable given that
75-85% of refugees are in low/middle-income countries. Additional
sources:
https://www.cgdev.org/blog/costs-hosting-refugees-oecd-countries-and-why-uk-outlier
|
https://www.unhcr.org/sites/default/files/2024-11/UNHCR-WB-global-cost-of-refugee-inclusion-in-host-country-health-systems.pdf
.223.
Cryptopolitan. Uniswap labs treasury size.
Cryptopolitan https://www.cryptopolitan.com/uniswap-dao-governance-attacks-2025/
(2025)
Uniswap is the largest DAO, holding
$5.4B in its treasury as of early 2025. The DAO manages a $5.4 billion
treasury, far surpassing the Ethereum Foundation’s $919 million.
Additional sources:
https://www.cryptopolitan.com/uniswap-dao-governance-attacks-2025/ |
https://blockchainreporter.net/top-15-daos-ranked-by-treasury-size-mantle-uniswap-optimism-lead-the-pack
.224.
Research, P. US clinical trials market size
2024. Precedence Research https://www.precedenceresearch.com/us-clinical-trials-market
The U.S. clinical trials market was estimated at
$45.07 billion in 2024, representing approximately 54% of the global
market. Additional sources:
https://www.precedenceresearch.com/us-clinical-trials-market
.225.
Group, C. F. Thickness of US currency.
Certified Financial Group https://financialgroup.com/2021/10/21/what-does-one-trillion-dollars-look-like/
(2021)
All U.S. paper currency measures
0.0043 inches thick. A trillion dollars in $100 bills would be just over
678.66 miles tall. If we stacked $11.4 trillion in $100 bills, the stack
would be approximately 7,737 miles tall. Additional sources:
https://financialgroup.com/2021/10/21/what-does-one-trillion-dollars-look-like/
|
https://lasvegassun.com/news/2011/jul/16/putting-debt-physical-perspective/
.227.
NEA. U.s. Federal government spending on the
arts. NEA https://www.arts.gov/news/press-releases/2023/statement-national-endowment-arts-chair-maria-rosario-jackson-presidents-fiscal-year-2024-budget
(2024)
The National Endowment for the Arts
received an appropriation of $207.0 million for FY2024, with actual
spending reaching $220 million. Additional sources:
https://www.arts.gov/news/press-releases/2023/statement-national-endowment-arts-chair-maria-rosario-jackson-presidents-fiscal-year-2024-budget
|
https://www.usaspending.gov/agency/national-endowment-for-the-arts
.228.
USASpending.gov. U.s. Federal government
spending on education. USASpending.gov https://www.usaspending.gov/agency/department-of-education
(2024)
The Department of Education spent
$268.4 billion in fiscal year (FY) 2024. About $80 billion consisted of
discretionary appropriations that Congress allocates annually.
Additional sources:
https://www.usaspending.gov/agency/department-of-education |
https://www.ed.gov/sites/ed/files/about/overview/budget/budget24/summary/24summary.pdf
.229.
CMS. U.s. Federal government spending on
healthcare. CMS https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet
(2024)
Healthcare: $1.5 trillion (for not
dying, but slowly) Additional sources:
https://www.cms.gov/data-research/statistics-trends-and-reports/national-health-expenditure-data/nhe-fact-sheet
.230.
NASA. U.s. Government use of prize and bounty
programs. NASA https://www.nasa.gov/news-release/nasa-and-x-prize-announce-winners-of-lunar-lander-challenge/
NASA’s Centennial Challenge, initiated in 2005,
has paid out more than $7.6 million. The Ansari XPRIZE demonstrated
significant leverage: $10 million was awarded to the winner, but more
than $100 million was invested in new technologies in pursuit of the
prize. NASA launched its own incentive scheme in 2005 called Centennial
Challenges. Additional sources:
https://www.nasa.gov/news-release/nasa-and-x-prize-announce-winners-of-lunar-lander-challenge/
| https://www.xprize.org/past-challenges |
https://www.herox.com/blog/985-prize-challenges-governments-secret-weapon-for-inn
.231.
Defense, D. of. U.s. Military budget.
Department of Defense https://www.military.gov/Spotlights/FY2024-Defense-Budget/
(2024)
The fiscal year 2024 (FY2024) military
budget was signed into law on December 22, 2023 at $841.4 billion. The
Fiscal Year 2024 Defense Appropriations Act provides $831.781 billion in
total funding. Additional sources:
https://www.defense.gov/Spotlights/FY2024-Defense-Budget/ |
https://www.congress.gov/crs-product/R47582
.232.
Treasury, U. U.s. National debt. US
Treasury https://fiscaldata.treasury.gov/americas-finance-guide/national-debt/
The gross national debt of the United States
reached $36 trillion in November 2024, and has now reached $38 trillion
as of late October 2025. Additional sources:
https://fiscaldata.treasury.gov/americas-finance-guide/national-debt/ |
https://www.crfb.org/press-releases/gross-national-debt-reaches-36-trillion
.233.
Wikipedia. US GDP growth rate post-WWII.
Wikipedia https://en.wikipedia.org/wiki/Post–World_War_II_economic_expansion
US GDP increased from $228 billion in 1945 to
just under $1.7 trillion in 1975. Average real GDP growth from 1950 to
1980 was around 4.1% annually, compared to 3.1% from 1981 to 2008.
Additional sources:
https://en.wikipedia.org/wiki/Post–World_War_II_economic_expansion |
https://www.stlouisfed.org/timely-topics/house-prices-homeownership-rise
.234.
Fed, St. L. US home ownership rate increase
post-WWII. St. Louis Fed https://www.stlouisfed.org/timely-topics/house-prices-homeownership-rise
The homeownership rate increased nearly 20
percentage points between 1940 and 1960, from 43.6% to 61.9%, the
largest change in American homeownership in the past 100 years.
Additional sources:
https://www.stlouisfed.org/timely-topics/house-prices-homeownership-rise
|
https://www.census.gov/data/tables/time-series/dec/coh-owner.html
.235.
Wikipedia. US military spending reduction after
WWII. Wikipedia https://en.wikipedia.org/wiki/Demobilization_of_United_States_Armed_Forces_after_World_War_II
(2020)
Peaking at over $81 billion in 1945,
the U.S. military budget plummeted to approximately $13 billion by 1948,
representing an 84% decrease. The number of personnel was reduced almost
90%, from more than 12 million to about 1.5 million between mid-1945 and
mid-1947. Defense spending exceeded 41 percent of GDP in 1945. After
World War II, the US reduced military spending to 7.2 percent of GDP by
1948. Defense spending doubled from the 1948 low to 15 percent at the
height of the Korean War in 1953. Additional sources:
https://en.wikipedia.org/wiki/Demobilization_of_United_States_Armed_Forces_after_World_War_II
|
https://www.americanprogress.org/article/a-historical-perspective-on-military-budgets/
|
https://www.stlouisfed.org/on-the-economy/2020/february/war-highest-military-spending-measured
|
https://www.usgovernmentspending.com/defense_spending_history
.236.
Foundation, T. Length of the u.s. Tax code.
Tax Foundation https://taxfoundation.org/blog/how-many-words-are-tax-code/
(2024)
The Internal Revenue Code comprises
6,871 pages. When including federal tax regulations, federal tax laws
and regulations together total over 10 million words (IRC: 2,412,000
words; regulations: 7,655,000 words). Additional sources:
https://taxfoundation.org/blog/how-many-words-are-tax-code/ |
https://www.ntu.org/foundation/detail/tax-complexity-2024-it-takes-americans-billions-of-hours-to-do-their-taxes
.237.
Bureau, U. C. Number of registered or eligible
voters in the u.s. US Census Bureau https://www.census.gov/newsroom/press-releases/2025/2024-presidential-election-voting-registration-tables.html
(2024)
73.6% (or 174 million people) of the
citizen voting-age population was registered to vote in 2024 (Census
Bureau). More than 211 million citizens were active registered voters
(86.6% of citizen voting age population) according to the Election
Assistance Commission. Additional sources:
https://www.census.gov/newsroom/press-releases/2025/2024-presidential-election-voting-registration-tables.html
|
https://www.eac.gov/news/2025/06/30/us-election-assistance-commission-releases-2024-election-administration-and-voting
.238.
1,
C. from. Value captured by 1% treaty of $27+ billion annually.
A 1% treaty redirects 1% of global military
spending ($2.7T × 1% = $27.2B) to pragmatic clinical trials, with 10% of
this flow (2.7B annually) distributed to VICTORY Incentive Alignment
Bondholders as returns.
239.
VA. Veteran healthcare cost projections.
VA https://department.va.gov/wp-content/uploads/2025/06/2026-Budget-in-Brief.pdf
(2026)
VA budget: $441.3B requested for FY
2026 (10% increase). Disability compensation: $165.6B in FY 2024 for
6.7M veterans. PACT Act projected to increase spending by $300B between
2022-2031. Costs under Toxic Exposures Fund: $20B (2024), $30.4B (2025),
$52.6B (2026). Additional sources:
https://department.va.gov/wp-content/uploads/2025/06/2026-Budget-in-Brief.pdf
| https://www.cbo.gov/publication/45615 |
https://www.legion.org/information-center/news/veterans-healthcare/2025/june/va-budget-tops-400-billion-for-2025-from-higher-spending-on-mandated-benefits-medical-care
.240.
Graham, D. (FDA). |. L. Vioxx cardiovascular
deaths (rofecoxib). PMC: FDA incapable of protecting against another
Vioxx https://pmc.ncbi.nlm.nih.gov/articles/PMC534432/
(2007)
Graham testimony (2004):
88,000-139,000 U.S. heart attacks/strokes from Vioxx; up to 55,000
deaths (40% fatality rate) Lancet study estimate: 88,000 Americans had
heart attacks from Vioxx; 38,000 died FDA memo (2004): Vioxx contributed
to 27,785 heart attacks and sudden cardiac deaths (1999-2003) High-dose
Vioxx: Tripled risk of heart attacks and sudden cardiac death
Prescriptions: 92.8 million U.S. prescriptions 1999-2003 Withdrawn:
September 30, 2004 after APPROVE trial showed cardiovascular risks Note:
Vioxx case demonstrates failure of passive post-market surveillance
(FAERS) to detect safety signals in time. Voluntary reporting missed
cardiovascular risks for years despite millions of prescriptions
Additional sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC534432/ |
https://www.npr.org/2007/11/10/5470430/timeline-the-rise-and-fall-of-vioxx
|
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(05
.241.
CNBC. Warren buffett’s career average
investment return. CNBC https://www.cnbc.com/2025/05/05/warren-buffetts-return-tally-after-60-years-5502284percent.html
(2025)
Berkshire’s compounded annual return
from 1965 through 2024 was 19.9%, nearly double the 10.4% recorded by
the S&P 500. Berkshire shares skyrocketed 5,502,284% compared to the
S&P 500’s 39,054% rise during that period. Additional sources:
https://www.cnbc.com/2025/05/05/warren-buffetts-return-tally-after-60-years-5502284percent.html
|
https://www.slickcharts.com/berkshire-hathaway/returns
.242.
University, U. Number of armed conflicts since
1945. Uppsala University https://ucdp.uu.se/
The AKUF dataset documents 218 wars and violent
conflicts since 1945. The Uppsala Conflict Data Program (UCDP) recorded
40 armed conflicts in 2014 (highest since 1999, with 11 defined as
wars). Peak year 1991 saw 51 active conflicts. Additional sources:
https://ucdp.uu.se/ |
https://en.wikipedia.org/wiki/Uppsala_Conflict_Data_Program
.243.
Science/AAAS. Estimated annual cost of
repeating failed experiments due to non-publication of results.
Science/AAAS https://www.science.org/content/article/study-claims-28-billion-year-spent-irreproducible-biomedical-research
(2020)
Up to 50.0% of published preclinical
research is irreproducible, with an estimated annual cost of $28 billion
in the U.S. alone. This is based on $56B annual spending on preclinical
research × 50.0% irreproducibility rate. Main causes: reagents/materials
(36%), study design (28%), data analysis (25%), protocols (11%).
Additional sources:
https://www.science.org/content/article/study-claims-28-billion-year-spent-irreproducible-biomedical-research
|
https://www.idbs.com/2020/11/replicating-science-28-billion-is-wasted-every-year-in-the-us-alone/
.244.
Forum, W. E. & Public Health, H. S. of.
WEF/harvard NCD cost ($47T, 2011-2030). World Economic Forum and
Harvard School of Public Health https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf
(2011)
The cumulative output loss due to
non-communicable diseases (NCDs) under a ’business as usual’ scenario is
estimated to be US47trillion.Thislossrepresents75%ofglobalGDPin2010(US
63 trillion). Additional sources:
https://www3.weforum.org/docs/WEF_Harvard_HE_GlobalEconomicBurdenNonCommunicableDiseases_2011.pdf
.245.
Trust, W. Wellcome trust endowment size.
Wellcome Trust https://cms.wellcome.org/sites/default/files/2024-01/Wellcome-Trust-Annual-Report-and-Financial-Statements-2023.pdf
(2023)
$38B Additional sources:
https://cms.wellcome.org/sites/default/files/2024-01/Wellcome-Trust-Annual-Report-and-Financial-Statements-2023.pdf
.246.
World’s Resources, S. the. War spending vs WHO
budget. Share the World’s Resources https://sharing.org/information-centre/news/world-health-organisations-annual-budget-equivalent-global-military/
The WHO’s annual budget of US$2.1 billion is
equivalent to global military expenditure every eight hours. WHO
Director-General noted that US$2.1 billion is the price of one stealth
bomber. A 1% increase in military spending results in a 0.62% decrease
in health spending globally. Additional sources:
https://sharing.org/information-centre/news/world-health-organisations-annual-budget-equivalent-global-military/
| https://pmc.ncbi.nlm.nih.gov/articles/PMC9174441/
.247.
Organization, W. H. World Health
Organization https://www.who.int/activities/choosing-interventions-that-are-cost-effective-(who-choice
In the CHOICE project, we have used a threshold
of three times GDP per capita for an intervention to be considered
’cost-effective’ and a threshold of one times GDP per capita to be
considered ’very cost-effective’. Additional sources:
https://www.who.int/activities/choosing-interventions-that-are-cost-effective-(who-choice
.248.
Based on WHO Global Health Estimates showing 55
million annual deaths / 365 days = 150, 000. per day |. W. 150,000
deaths per day from all causes. Based on WHO Global Health Estimates
showing 55 million annual deaths / 365 days = 150 https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
(2024)
Approximately 150,000 people die every
day worldwide. The majority of these deaths (over 100,000) are from
non-communicable diseases including cardiovascular diseases, cancers,
chronic respiratory diseases, and diabetes. Additional sources:
https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
.249.
Journal, G. P. World bank cost to eradicate
extreme poverty. Global Policy Journal https://www.globalpolicyjournal.com/blog/25/07/2024/new-estimates-cost-ending-poverty
(2024)
Jeffrey Sachs estimated $175 billion
per year for 20 years (less than 1% of combined income of richest
countries). Recent UNU-WIDER research: $70B/year for extreme poverty
($2.15/day threshold) or $325B/year for absolute poverty ($3.65/day).
This is only 0.1-0.6% of OECD high-income countries’ GNI. Additional
sources:
https://www.globalpolicyjournal.com/blog/25/07/2024/new-estimates-cost-ending-poverty
|
https://borgenproject.org/how-much-does-it-cost-to-end-poverty/
.250.
Bank, W. World bank trade disruption cost from
conflict. World Bank https://www.worldbank.org/en/topic/trade/publication/trading-away-from-conflict
Estimated $616B annual cost from conflict-related
trade disruption. World Bank research shows civil war costs an average
developing country 30 years of GDP growth, with 20 years needed for
trade to return to pre-war levels. Trade disputes analysis shows tariff
escalation could reduce global exports by up to $674 billion. Additional
sources:
https://www.worldbank.org/en/topic/trade/publication/trading-away-from-conflict
| https://www.nber.org/papers/w11565 |
http://blogs.worldbank.org/en/trade/impacts-global-trade-and-income-current-trade-disputes
.251.
American Scientists, F. of. World nuclear
forces. Federation of American Scientists https://fas.org/issues/nuclear-weapons/status-world-nuclear-forces/
(2024)
As of early 2025, we estimate that the
world’s nine nuclear-armed states possess a combined total of
approximately 12,241 nuclear warheads. Additional sources:
https://fas.org/issues/nuclear-weapons/status-world-nuclear-forces/
.252.
Foundation, W. Worldcoin identity verification
scale. World Foundation https://world.org/blog/announcements/world-year-two
(2025)
World Network now spans 160 countries
and more than 14 million verified unique humans using iris biometric
scanning, demonstrating feasibility of global-scale biometric
verification. Additional sources:
https://world.org/blog/announcements/world-year-two
.253.
American Scientists, F. of. Cost of world war
II in today’s dollars. Federation of American Scientists https://fas.org/publication/costs_of_war/
WWII cost $4 trillion (today’s dollars).
Additional sources: https://fas.org/publication/costs_of_war/ |
https://online.norwich.edu/online/about/resource-library/cost-us-wars-then-and-now
.254.
Treasury, U. S. WWII war bonds. U.S.
Treasury https://en.wikipedia.org/wiki/War_bond.
255.
Prize, N. Discovery of induced pluripotent stem
cells (yamanaka factors). Nobel Prize https://www.nobelprize.org/prizes/medicine/2012/press-release/
(2012)
In 2006, Shinya Yamanaka and Kazutoshi
Takahashi showed that introducing four specific genes (Myc, Oct3/4,
Sox2, Klf4), known as Yamanaka factors, could convert somatic cells into
pluripotent stem cells. Yamanaka was awarded the 2012 Nobel Prize with
Sir John Gurdon for the discovery that mature cells can be reprogrammed
to become pluripotent. Additional sources:
https://www.nobelprize.org/prizes/medicine/2012/press-release/ |
https://en.wikipedia.org/wiki/Induced_pluripotent_stem_cell
.256.
ACS. ZINC-22 database (billions of compounds).
ACS https://pubs.acs.org/doi/10.1021/acs.jcim.2c01253
ZINC-22 contains tens of billions of purchasable
virtual molecules for drug discovery. Additional sources:
https://pubs.acs.org/doi/10.1021/acs.jcim.2c01253
.